INTRODUCTION {#sec1}
============

The study of bacterial gene regulation definitely took off with the pioneering and groundbreaking work on regulation of *lac* operon encoded enzyme synthesis in *Escherichia coli* (Jacob and Monod [@bib198], [@bib199]; Gilbert and Müller-Hill [@bib151], [@bib152]). Very importantly, it was rapidly realized that induction of the *lac* operon in the presence of its substrate and induction of a lysogen for bacteriophage lambda on the one hand and repression of amino acid biosynthesis genes and operons in the presence of the end product on the other are two manifestations of the same phenomenon: negative regulation of transcription initiation by a *trans*-acting DNA-binding transcription regulator (historical accounts by Maas [@bib254], [@bib255]). Since then, numerous distinct mechanisms of gene regulation have been identified. And most importantly, it has become increasingly clear that the expression of a single bacterial gene or operon is generally controlled not by one but by a combination of diverse mechanisms, potentially operating at different levels (transcription, translation) and stages (initiation, elongation, termination) of gene expression. Furthermore, and to add to the complexity and versatility of bacterial regulatory systems, the effect of a single regulatory molecule, regardless whether it is a DNA- or RNA-binding protein, a *cis*- or *trans*-acting small regulatory RNA, may vary depending on the specific target, its interaction with a small effector molecule or associated protein(s) and/or its interference/cooperation with other regulatory processes. This review provides an extensive overview of the various mechanisms modulating bacterial gene expression and illustrates the versatility of bacterial regulation, the intertwinement of regulatory mechanisms and the integration of multiple signals to generate an adapted regulatory response in function of environmental growth conditions and cellular needs. Much of the information provided here is derived from *E. coli*, still the best-studied microorganism. However, the underlying basic principles of these regulatory mechanisms are more generally valid for both Gram-negative and Gram-positive organisms, even though the target of a specific regulatory molecule may differ and a specific gene or operon may be regulated by a different mechanism in distinct bacteria. This is among others (a. o.) illustrated below for regulation by the alarmone ppGpp and of pyrimidine biosynthesis in the Gram-positive soil bacterium *Bacillus subtilis*.

As bacterial gene regulation mechanisms are mostly multi-layered and intricate, they are generally too complex to be incorporated as such in the design of synthetic circuits. However, once fully unraveled appealing properties of well-characterized isolated *cis*- and *trans*-acting basic gene expression and regulatory elements (parts) can be captured, engineered and further optimized as standardized parts for application in synthetic biology. In this review, we emphasize the interest of various regulatory systems for such SynBio applications. Profound knowledge of transcriptional and post-transcriptional gene regulatory mechanisms is thus not only of fundamental interest, but it may also lead to economically/industrially relevant applications and applications in human and animal health care, such as diagnostics, therapeutics, bioremediation, the development of specific gene silencing antibacterial drugs or the construction of well-characterized artificial gene expression systems for microbial synthesis of diverse (bio)chemicals from renewable resources. The latter is gaining interest as a valuable alternative to the classical (petrochemical) and frequently environmentally less friendly production schemes and methods (Jullesson *et al.*[@bib204]). Synthetic biology for microbial production relies a. o. on the construction of stable, predictable and tunable orthogonal gene expression systems showing maximal independence of and minimal interference with the host metabolism in order to avoid an important burden (Mutalik *et al.*[@bib292]; Singh [@bib389]; Wu *et al.*[@bib445]). Orthogonal gene expression and orthogonality of gene expression and regulatory elements are used in the context of this review, and more broadly in synthetic biology, to indicate the use of components (naturally occurring heterologous or artificial) that are functionally insulated from the action of the endogenous gene expression and regulatory machineries, and ideally only recognize their cognate elements. Thus, heterologous orthogonal sigma factors introduced in a host will only bind to their cognate promoters introduced in this host and not to promoters of the endogenous genes and neither will they cross-react among them. Similarly, orthogonal ribosomes will only bind their cognate ribosome-binding sites (RBS). However, it is important to realize that orthogonal gene expression is never completely independent of the host since transcription and translation will generally still rely on some components of the host\'s basal gene expression machineries or at least require its metabolic energy providing machinery and other cellular resources. Nevertheless, the use of orthogonal gene regulatory elements provides a means to modulate and optimize as desired the expression of a specific set of genes without considerably affecting the vast majority of the endogenous ones, and contributes to limit metabolic burden. The rational design of such expression systems requires 'toolboxes' containing well-characterized 'parts' including promoter and ribosome-binding sites of various strengths (libraries), and regulatory elements, which can be assembled in a combinatorial manner (De Mey *et al.*[@bib111]; Lucks *et al.*[@bib251]; Davis, Rubin and Sauer [@bib106]; Brewster, Jones and Phillips [@bib47]; Kahl and Endy [@bib206]; Tripathi, Zhang and Lin [@bib417]; Bradley, Buck and Wang [@bib45]; Rangel-Chavez, Galan-Vasquez and Martinez-Antonio [@bib345]). In this respect, alternative sigma factors, DNA- and RNA-binding regulatory proteins, riboswitches and small regulatory RNAs are among the regulatory elements that hold great promise, as further developed in this review. However, it should be stressed that optimizing gene expression addresses only one aspect of synthetic circuits. Other major bottlenecks in heterologous production may be related to feedback inhibition or allosteric regulation of enzyme activity, protein folding and stability, post-translational modifications, etc., but this is beyond the scope of this review.

Basal bacterial transcription and translation: tightly coupled processes {#sec1-1}
------------------------------------------------------------------------

Gene expression occurs in two steps, transcription and translation, which in bacteria are tightly coupled in space and time (Fig. [1A](#fig1){ref-type="fig"}) (McGary and Nudler [@bib258]). This coupling is an absolute necessity due to the generally very short half-life of bacterial mRNA molecules, which is on average a few minutes only (Rauhut and Klug [@bib346]). Furthermore, various regulatory mechanisms may affect the rate of mRNA degradation (positively or negatively) and the accessibility of mRNAs for the translation machinery, which again has an effect on mRNA stability (see the section Regulation of mRNA stability). Thus, transcription, translation and mRNA degradation are tightly interconnected processes.

![Bacterial transcription and translation is coupled. (**A**) Simplified schematic view of mRNA and protein synthesis with several RNA polymerase (RNAP) molecules simultaneously transcribing a single gene, and several ribosomes translating a single monocistronic mRNA. Transcription starts with binding of RNAP holoenzyme to the promoter region, mRNA synthesis proceeds in the direction 5΄ to 3΄ and stops at a Rho-dependent or -independent terminator. In both instances, transcription termination is accompanied by release of the mRNA molecule and dissociation of RNAP from the DNA template. Notice that during transcription elongation σ (blue colored) may (as in the figure) or may not dissociate from the complex. Translation by fully assembled 70S ribosomes (after initial binding of the 30S subunit to the RBS) starts at the initiation codon (mostly AUG, positioned in the P site of the ribosome), proceeds in the direction N-terminus to C-terminus and stops at a nonsense codon. Translation termination is accompanied by the release of the polypeptide chain from the tRNA and recycling of the ribosomes in separate 30S and 50S subunits. The magenta colored segment near the 5΄-end of the mRNA represents the ribosome-binding site (RBS) that comprises the Shine--Dalgarno sequence and the initiation codon. 5΄-UTR and 3΄-UTR correspond to untranslated regions of the mRNA near its 5΄- and 3΄-end, respectively. For simplicity, initiation, elongation and termination factors are not shown (see Box [1](#box1){ref-type="boxed-text"} for more information on bacterial transcription and translation). (**B**) Schematic representation of the RNAP holoenzyme composed of the core enzyme (α~2~ββ΄ω) and a σ factor that is responsible for promoter recognition. UP is the upstream promoter element that is contacted by α-CTD, whereas the --10 and --35 promoter elements are contacted by different parts of σ (see Fig. [2C](#fig2){ref-type="fig"} for details). Ext represents the extended --10 promoter element and Disc the discriminator site. TSS represents the transcription start, which is mostly a purine. Sequences and distances correspond to the consensus promoter for the housekeeping σ factor (σ^70^) of *E. coli*. (**C**) Schematic view of an elongating fully assembled 70S ribosome with three binding sites for tRNA molecules. A, the aminoacyl site with an incoming aminoacylated tRNA selected on basis of codon--anticodon complementarity; P, the peptidyl site with a tRNA carrying the growing peptide chain; and E, the exit site for binding of an uncharged tRNA after transfer of the growing peptide chain from the P site to the A site-bound tRNA followed by a translocation cycle.](fuz001fig1){#fig1}

Bacterial transcription is performed by a single RNA polymerase (RNAP), which consists of a catalytic core (E), with subunit composition α~2~ββ΄ω, that associates with a sigma factor (σ) to form the holoenzyme (Eσ) (Fig. [1B](#fig1){ref-type="fig"}). More information on the composition of the basal transcription apparatus, the different stages in transcription initiation and processes of transcription termination is provided in Box [1](#box1){ref-type="boxed-text"}. σ factors ensure specific promoter recognition by directly binding to two conserved hexanucleotide boxes centered around the positions --35 and --10 (Pribnow box) with respect to the transcription initiation site (+1) for σ^70^ family members, and positions --24 and --12 for σ^54^ family members (Figs [1B](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}) (Saecker, Record and deHaseth [@bib367]; Cho *et al.*[@bib91]). These hexanucleotide stretches constitute the major specificity determinants of the promoter and are connected by a spacer of conserved length but variable sequence, though spacer and surrounding region sequences may also contribute to promoter specificity, as recently demonstrated for extra-cytoplasmic function (ECF) σ factors from *B. subtilis* (Gaballa *et al.*[@bib146]). Besides a major housekeeping σ factor bacteria generally contain several alternative σ factors (Mittenhuber [@bib281]). They are used to direct the synthesis of specific sets of genes by interacting with specific, conserved promoter elements (Fig. [2](#fig2){ref-type="fig"}). It appears that the reduced capacity of alternative σ factors to melt promoter sequences ensures their more stringent promoter recognition compared to the housekeeping σ (Koo *et al.*[@bib219]). Many promoter regions contain binding sites for more than one σ factor to ensure transcription in different growth conditions. Direct sequence-specific DNA binding by a subunit of RNAP is unique to the bacterial domain of life. It is already a form of gene regulation, and one that holds great promise for exploitation in the design of orthogonal synthetic circuits (see the section Alternative σ factors for orthogonal expression of synthetic circuits). Mutations affecting the conserved hexanucleotide promoter elements generally have drastic effects on the transcription initiation frequency and promoter specificity. In contrast, randomizing the connecting linker sequence allows tuning of the transcription initiation frequency and promoter libraries exhibiting a wide range of expression levels were constructed for various organisms including Gram-negative and Gram-positive bacteria (Solem and Jensen [@bib394]; De Mey *et al.*[@bib111]; Dehli, Solem and Jensen [@bib109]; Rytter *et al.*[@bib365]; Gilman and Love [@bib153]; Guiziou *et al.*[@bib168]). This proved to be possible without loss of specificity/orthogonality (Bervoets *et al.*[@bib32]).

###### The basal bacterial transcription and translation machineries

The basal bacterial transcription apparatus. In bacteria, all RNA species are synthesized by a single RNA polymerase composed of a core enzyme (α~2~ββ΄ω) that associates with a sigma factor (σ) (Fig. [1A and B](#fig1){ref-type="fig"}). All subunits of the core enzyme are highly conserved in sequence and structure among bacteria, and homologs of the core subunits are also present in Eukarya and Archaea (Korkhin *et al.*[@bib220]; Werner and Grohmann [@bib435]). In contrast, σs that associate with the core and provide promoter-specific recognition are unique to Bacteria but highly variable in sequence, size and domain structure (Gruber and Gross [@bib165]; Haugen, Ross and Gourse [@bib176]; Feklístov *et al.*[@bib132]) as further detailed in the main body of the text (Fig. [2](#fig2){ref-type="fig"}). Most bacteria possess several σ factors, a primary housekeeping (also called vegetative) σ factor (σ^70^, also designed σ^D^ in *E. coli*, σ^A^ in many other bacteria) that is used for transcription initiation of all unconditionally essential genes and most genes whose product is required in all growth conditions, and a variable number of alternative sigma factors that are used to express specific sets of genes in response to particular stress conditions, the assembly and function of flagella, chemotaxis and certain developmental processes (Paget [@bib310]; Davis *et al.*[@bib107]). All σ factors in a cell compete for binding to the same core enzyme and interact with two conserved hexanucleotide stretches in the promoter, centered at position --10 (also called Pribnow box) and --35 with respect to the transcription initiation site (+1) for the housekeeping σ and other sigma-70 family members (Mauri and Klump [@bib270]; Kandavalli, Tran and Ribeiro [@bib208]) (Fig. [1B](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). Ideally these hexanucleotides are separated by a 17 bp spacer. Some promoters (generally with a highly degenerated or no --35 element) have an extended --10 sequence, with the conserved TGN dinucleotide immediately preceding the Pribnow box (Fig. [1B](#fig1){ref-type="fig"}). Strong promoters may also contain a UP element (Upstream Promoter), an A+T-rich sequence preceding (--40 to --60) the --35 box, which is contacted by the C-terminal domain of one or both α-subunits (α-CTD) (Fig. [1B](#fig1){ref-type="fig"}) (Ross *et al.*[@bib360]; Gaal *et al.*[@bib145]; Estrem *et al.*[@bib128]). It appears that structural properties of promoter regions correlate with functional features (Meysman *et al.*[@bib275]). The promoter sequence will to a large extent determine the basal transcription initiation frequency but this frequency may be strongly influenced (enhanced, reduced) by various regulatory mechanisms. These mechanisms are the major focus of this review and are extensively discussed in the main body of the text. Initial binding of Eσ to the promoter DNA generates a closed binary complex (RP~c~) that subsequently isomerizes to the open complex (RP~o~), which is characterized by local DNA melting over a distance of 13 bp (from position −11 to +3). Incorporation of the first nucleotide generates the ternary initiating complex (RP~i~), which upon further transcript elongation will generally go through a number of abortive initiation cycles whereby short RNA products (generally ≤12 nt) are released, before evolving into the elongating complex (RP~e~) that is characterized by promoter escape and productive RNA synthesis. This transition from RPi to RPe is a

rate-limiting step in transcription initiation (generally 1 to 2 s) and hence already a form of gene regulation since as long as the RNAP has not liberated the promoter a new initiation round cannot be started. Though it is generally stated that the σ factor dissociates from the core RNAP upon transcription elongation, and must do so to free the RNA exit channel, it appears now that *E. coli* σ^70^ may remain associated with the elongating enzyme (Harden *et al.*[@bib173]). For more detailed information on the mechanism of bacterial transcription initiation, the reader is referred to excellent and recent reviews (Saecker, Record and deHaseth [@bib367]; Grylak-Mielnicka *et al.*[@bib166]; Lloyd-Price *et al.*[@bib244]; Henderson *et al.*[@bib183]).

Bacterial genes are frequently grouped in operons and a polycistronic transcription unit may cover up to tens of genes that are coordinately expressed from a common control region. The transcription elongation rate is not uniform but discontinuous and influenced by local pause sites and RNAP-associated factors that play key regulatory roles (Artsimovitch and Landick [@bib15]). Operons may contain internal secondary promoters (generally rather weak and constitutive) to allow adjustment of the expression of downstream genes. Transcription termination can occur in two distinct manners, depending on the termination signal. Intrinsic or Rho-independent termination occurs at G+C-rich stem-loop structures immediately followed by a stretch of U-residues in the mRNA. These secondary RNA structures are also exploited in regulatory systems such as transcriptional attenuation, where they are stabilized and used to prematurely stop the RNA polymerase in particular conditions only (Henkin and Yanofsky [@bib184]). Rho-dependent termination makes use of the Rho protein and its cofactor NusG. Rho is a hexameric ring-shaped molecule with ATPase activity that binds to a conserved *rut* site in the RNA, moves along the transcript and forces dissociation of the transcription complex. In *E. coli*, intrinsic and Rho-dependent termination contribute more or less equally to transcription termination (Ray-Soni, Bellecourt and Landick *et al.*[@bib348]). Besides its essential role in generating the 3΄-end of a transcript, Rho is also involved in premature transcription termination as a regulatory process of gene expression. About 27% of all annotated *E. coli* genes have 5΄-untranslated sequences (5΄-UTR) longer than 80 nucleotides (nt) that are natural substrates for Rho-dependent termination and in many instances this premature termination process is counteracted by the binding of small regulatory RNAs (sRNAs) to the 5΄-UTR (Sedlyarova *et al.*[@bib377]). Rho-dependent termination and targeting of nascent transcripts that are not translated efficiently is also essential to limit antisense transcript accumulation and concommittant R-loop formation (Raghunathan *et al.*[@bib343]). The importance of Rho and its cofactor NusG is underscored by the observation that both *rho* and *nusG* are essential genes in *E. coli* and many other bacteria. For recent reviews on transcription termination and the multifunctional role of Rho, see Peters, Vangeloff and Landick ([@bib329]), Grylak-Mielnicka *et al.* ([@bib166]), Kriner, Sevostyanova and Groisman ([@bib224]), Porrua, Boudvillain and Libri ([@bib336]) and Ray-Soni, Bellecourt and Landick ([@bib348]).

The basal bacterial translation apparatus. Bacterial protein synthesis is performed on ribosomes, 70S particles composed of a small (30S) and a large (50S) subunit that assemble on mRNA (Fig. [1A](#fig1){ref-type="fig"}). As transcription, translation consists of three major phases, initiation, elongation and termination, followed by ribosome recycling (Laursen *et al.*[@bib232]). Both subunits consist of ribosomal RNA (16S rRNA for the 30S, 5S and 23S rRNA for the 50S subunit) associated with a large number of ribosomal proteins. Peptide bond formation is catalyzed by the 23S rRNA; hence, it is a ribozyme (RNA molecule with catalytic activity) that uses the energy of the acyl bond on the aminoacylated tRNA (aa-tRNA) to drive the condensation reaction. Ribosomes bear three binding sites for tRNA: (i) the A (aminoacyl) site that accepts the incoming aa-tRNA (except the initiator tRNA~i~, which frequently carries formylmethionine in bacteria, and immediately enters the P site), a process that is based on codon--anticodon recognition; (ii) the P (peptidyl) site, which holds the tRNA attached to the growing peptide chain; and (iii) the E (exit) site that bears the deacylated tRNA before it exits the ribosome in the next translocation cycle (Fig. [1C](#fig1){ref-type="fig"}). Translation initiation starts with the cooperative binding of mRNA and the translation initiation factors IF1 and GTP-bound IF2 to respectively that part of the A and P sites present on the small subunit, which at this stage is already associated with initiation factor IF3 bound in the E site. GTP-bound IF2 brings the charged tRNA~i~ to the P site. Subsequent GTP hydrolysis is accompanied by the assembly of the full ribosome and dissociation of the initiation factors. Translation generally starts with the first AUG codon (or more rarely and less efficiently with GUG or UUG) following the ribosome-binding site (RBS; alias Shine--Dalgarno \[SD\]), which is complementary to the 3΄-end of 16S rRNA of the 30S subunit. All subsequent aa-tRNAs for chain elongation are brought to the A site of assembled 70S ribosomes in association with GTP-bound elongation factor EF-Tu, which after GTP hydrolyses is recycled with the use of GTP and EF-Ts. Coordinated translocation along the mRNA is performed with the help of GTP-bound EF-G. Hence, protein synthesis is an energetically very costly process that requires one ATP (for the aminoacylation of tRNA for the corresponding amino-acyl tRNA synthetase) and two GTP molecules for every amino acid that is incorporated. Protein synthesis will terminate when one of three stop codons (UAA, UAG, UGA or a combination) is encountered and occupies the A site. This process requires a termination factor of class-I (RF1 or RF2) and class-II (RF3, a GTP-ase) and hydrolysis of another GTP molecule to release the peptide chain from the peptidyl-tRNA and the dissociation of the release factors. Termination is followed by dissociation of the 70S particles into 30S and 50S constituents (with the help of RRF, the ribosomal release factor, and IF3), a requisite for their recycling and reuse in a next initiation round. In polycistronic mRNAs, each open reading frame (ORF) is generally preceded by an RBS. The efficiency of protein synthesis strongly depends on the complementarity of the SD sequence with the 3΄-end of 16S rRNA, its distance to the initiation codon, the nature of the latter and of the subsequent codons near the N-terminus of the protein and the concentration of aa-tRNAs in the cell. The latter will influence the velocity of ribosome movement and this is exploited in regulatory mechanisms of the attenuation type, which may affect both premature transcription termination and translation initiation (Henkin and Yanofsky [@bib184]). For more information on bacterial translation, see Moreno *et al.* ([@bib287]), Ramakrishnan ([@bib344]) and Laursen *et al.* ([@bib232]).

![Domain composition of σ factors and their interaction with cognate promoter sequences. (**A**) The seven σ factors of *E. coli*, which all bind competitively to similar regions of the unique core RNAP but interact with specific promoter sequences centered around positions --10 and --35 for the six members of the σ^70^ family and around --12 and --35 for σ^N^, the sole representative of the σ^54^ family. Notice that some cross-talk may exist in the binding of alternative sigma factors to non-cognate promoter sequences as observed for the housekeeping σ^70^ and σ^S^ in *E. coli* and among members of the ECF (extracytoplasmic function) group of σ factors in general. (**B**) Function and division in four groups of the six σ^70^ family members of *E. coli* based on domain composition, and σ^54^ that forms a distinct family on its own. (**C**) Promoter structure and domain composition of the four groups of σ^70^ family members. NCR stands for non-conserved region. Arrows indicate interactions of specific subdomains of σ with promoter sequences. σ~1.1~ plays an inhibitory role in promoter binding. (**D**) Promoter structure and domain composition of σ^54^. RpoN is the region that specifically interacts with the --24 promoter region and is the most conserved domain among σ^54^ proteins. HTH stands for the helix-turn-helix motif that interacts with the --12 promoter sequence, and ELH for extra long helix. CBD is the RNAP core-binding domain. RI interacts with RIII and plays an inhibitory role, blocking the entry of the DNA template strand. It is also a site of contact for activator proteins. RII penetrates deeply in the DNA-binding channel and also plays an inhibitory role and has to be displaced in the transcribing complex.](fuz001fig2){#fig2}

Translation of bacterial mRNAs by ribosomes, with the help of translation initiation factors, starts with binding of the 30S subunit to the RBS, a short A+G-rich sequence, also called Shine--Dalgarno (SD) sequence, preceding the translation initiation codon (generally AUG) that is (partially) complementary to the 3΄-end of 16S rRNA (Ramakrishnan [@bib344]). More details on the basal bacterial translation machinery are provided in Box [1](#box1){ref-type="boxed-text"}. Translation starts as soon as the 5΄-end of the mRNA molecule has been synthesized, and several ribosomes may simultaneously translate a single mRNA molecule (polyribosomes) (Fig. [1A and C](#fig1){ref-type="fig"}). In general, each open reading frame (ORF) of a polycistronic mRNA is preceded by a RBS. Variations in the accessibility of the RBS by RNA-binding proteins or reversible trapping in double-stranded RNA structures may greatly affect the translation initiation frequency and hence constitute a form of gene regulation (Duval *et al.*[@bib124]). As with promoter sequences, variations in the RBS allow to tune the translation initiation frequency. RBS libraries have been constructed, algorithms have been developed and tools such as the RBS calculator allow the design of synthetic RBSs and to predict the rate of translation initiation on basis of the 5΄-mRNA sequence (Salis, Mirsky and Voigt [@bib370]; Salis [@bib369]; Egbert and Klavins [@bib125]; Guiziou *et al.*[@bib168]). Furthermore, an orthogonal ribosome--mRNA translation system (O-ribosome) was developed in which an orthogonal 16S rRNA that recognizes an altered SD sequence only translates its cognate O-mRNAs (Rackham and Chin [@bib342]; An and Chin [@bib9]; Liu, Kim and Jewett [@bib243]).

Need for gene regulatory mechanisms {#sec1-2}
-----------------------------------

Regulation of gene expression is pivotal for optimal energy management and the generation of a swift and adapted metabolic response to fluctuating environmental conditions and stresses. In combination with regulation of enzyme activity (enzymotropic regulation by a. o. feedback inhibition, allosteric regulation and (reversible) chemical modifications) that operates at a different time scale, regulation of gene expression at transcriptional and post-transcriptional level avoids the accumulation of pathway intermediates and wasteful consumption of resources and energy. Hence, bacteria that have a more varied lifestyle and exhibit a considerable nutrient and metabolic versatility, such as the Gram-positive soil bacterium *B. subtilis* and the Gram-negative opportunistic pathogen *Pseudomonas aeruginosa*, bear a much larger number and variety of genes encoding regulatory elements including transcriptional regulators, two-component systems and alternative σ factors than organisms such as intracellular pathogens that thrive in more stable biotopes (Pérez-Rueda, Janga and Martínez-Antonio [@bib327]; Pérez-Rueda and Martínez-Nuñez [@bib328]; Freyre-González *et al.*[@bib142]; Pérez-Rueda *et al.*[@bib326]). At the level of protein production, regulation of transcription initiation has the advantage that it affects the very first step in the process and hence is most interesting in terms of energy saving. On the other hand, regulation of translation initiation, the most regulated step in translation (Duval *et al.*[@bib124]), has the advantage that it has an immediate impact on protein synthesis. Various quantitative proteomic and RNA-Seq studies performed with diverse bacteria have shown that a large part of gene regulation occurs at the post-transcriptional level, including translation initiation and elongation, but also proteolysis and sequestration, especially in response to different stress conditions (Nie, Wu and Zhang [@bib301]; Lu *et al.*[@bib248]; de Sousa *et al.*[@bib115]; Dressaire *et al.*[@bib122]; Picard *et al.*[@bib323], [@bib331]).

Regulation of gene expression by σ factor competition {#sec1-3}
-----------------------------------------------------

Besides their housekeeping σ factor, which is used for the synthesis of most products that are needed in all growth conditions, bacteria possess a variable number of alternative σ factors. As stated above, these recognize specific sets of promoter sequences but compete for binding to the limited pool of core RNAP (about 1300 molecules involved in transcription and another 700 free molecules in an *E. coli* cell) (Fig. [2A](#fig2){ref-type="fig"}) (Ishihama [@bib196]; Gruber and Gross [@bib165], Grigorova *et al.*[@bib163]; Feklístov *et al.*[@bib132]; Mauri and Klumpp [@bib270]; Davis *et al.*[@bib107]). This competition already constitutes a form of gene regulation and ensures a mechanism for cross-talk between different classes of genes. Furthermore, functional modules of genes transcribed with the same σ factor guarantee adaptability and evolvability (Binder *et al.*[@bib35]). σ factors generally control global switches in the gene expression profile, mainly in response to stress conditions, and cascades of alternative σ factors are used to coordinate gene expression in time and space (cellular compartmentalization). They steer complex cellular processes including sporulation in *B. subtilis*, photosynthesis and circadian rhythms in cyanobacteria, aerial hyphae production by *Streptomyces coelicolor* and lytic propagation of bacteriophages (Burbulys, Trach and Hoch [@bib52]; Hilbert and Piggot [@bib187]; Hinton *et al.*[@bib189]; Hinton [@bib188]). It is in the latter context that bacteriophage T4-encoded alternative σ factors, regulation of their activity by anti-σ factors, and cooperation with transcriptional activator proteins for the temporal and successive expression of viral genes have been discovered (Stevens [@bib403]; Minakhin and Severinov [@bib278]; Tagami *et al.*[@bib409]).

*Escherichia coli* has seven σ factors (Fig. [2A and B](#fig2){ref-type="fig"}) (Maeda, Fujita and Ishihama [@bib263]), but some other organisms have many more. Thus, the Gram-positive soil bacterium *B. subtilis* has 19 characterized/predicted σ factors, many of which are involved in sporulation, *S. coelicolor* encodes over 60 σ factors and the Gram-negative soil dwelling myxobacterium *Sorangium cellulosum* So0157--2 more than 100 (Mittenhuber [@bib281]; Kill *et al.*[@bib215]; Han *et al.*[@bib170]). Most alternative σ factors belong to the large σ^70^ family (Lonetto, Gribskov and Gross [@bib245]; Paget [@bib310]), with the exception of σ^54^ (σ^N^) that forms a distinct family on its own (Fig. [2C and D](#fig2){ref-type="fig"}) (Merrick [@bib272]). Whereas bacteria have in general multiple σ^70^ type factors, they commonly bear only one σ^54^ family member. σ^70^ family members are modular proteins and are divided into four groups based on sequence conservation and domain structure and composition (Fig. [2C](#fig2){ref-type="fig"}) (Campbell *et al.*[@bib58]; Paget and Helmann [@bib311]). Much information was retrieved from the crystal and co-crystal structures of σ^A^, the housekeeping σ factor from the extreme thermophilic Gram-negative bacterium *Thermus aquaticus* (Campbell *et al.*[@bib58]). Housekeeping σ factors generally belong to group 1 and are composed of four conserved domains connected by flexible linkers (Paget [@bib310]). Each domain is predicted to bind both core RNAP and DNA. Domain 1 (σ~1~) is unique to group 1 members and its N-terminal sequence (σ~1.1~) inhibits the binding of free σ factor to the promoter, unless the σ factor has bound core RNAP. This mechanism avoids promoter binding by an isolated σ subunit, which would result in frequent inhibitory and non-productive promoter occupation. Autoinhibition of DNA binding exerted by σ~1.1~ relies on its high negative charge, which allows it to act as a DNA mimic (Young, Gruber and Gross [@bib450]; Schwartz *et al.*[@bib376]). In addition, region 1.1 plays an important role in the interaction of the holoenzyme with DNA, whereby it facilitates open promoter complex formation (Wilson and Dombroski [@bib437]; Ruff, Record and Artsimovitch [@bib364]). Domain 2 (σ~2~) contains an exposed α-helix 2.2 predicted to form a primary interface with the core, whereas the region 2.3--2.4 helix interacts with the --10 promoter sequence. It contains aromatic residues important for DNA melting and interaction with the non-template strand of the --10 promoter sequence. Both σ~3~ and σ~4~ contain three α helices. One helix in σ~3~ interacts with the conserved TG dinucleotide of extended --10 promoters. Two helices in σ~4~ specifically interact with the --35 promoter element. σ factors belonging to group 2 are closely related to group 1 members but are generally dispensable for growth (at least in laboratory conditions). One of its best-studied members is *E. coli* σ^S^ (RpoS), responsible for the general stress and starvation response, and specific gene expression in the stationary growth phase (Landini *et al.*[@bib230]). Its concentration in the cell is highly regulated and varies depending on the nature of the stress and the growth conditions (see below for details). About 23% of all *E. coli* genes are regulated in response to changes in the level of σ^S^, though to a different degree (Wong *et al.*[@bib444]). A core regulon of 63 genes associated with Eσ^S^ upon transition from exponential to stationary phase growth was identified by chromatin immunoprecipitation-sequencing (ChIP-seq) (Peano *et al.*[@bib319]). A study performed with *Salmonella* further revealed that a large number of σ^S^ concentration-dependent genes are regulated at the protein level only, indicating an important role for post-transcriptional regulation (Lago *et al.*[@bib228]). In contrast to the housekeeping σ^0^ factor, σ^S^ was recently shown to adopt an open conformation in solution in which the folded σ~2~ and σ~4~ domains are interspersed by domains with a high degree of disorder (Cavaliere *et al.*[@bib67]). This open configuration of σ^S^ also provides insight into a possible mechanism for regulation of its activity by the chaperone Crl (see below). σ factors belonging to group 3 only contain the domains 2, 3 and 4 (Fig. [2C](#fig2){ref-type="fig"}). They are a. o. responsible for induction of gene expression upon heat shock, sporulation and flagellar biosynthesis. The σ factors from group 4 are among the smallest, bearing only domains σ~3~ and σ~4~. They constitute the ECF family, the largest and most divergent class of alternative σ factors (Helmann [@bib180]; Souza *et al.*[@bib397]; Campagne, Allain and Vorholt [@bib57]). They are generally involved in regulation of cell surface and transport systems, and are frequently co-transcribed with a *trans*-membrane anti-σ factor that interacts with and controls the activity of the cognate σ factor.

σ^54^ factors were initially identified in the context of nitrogen assimilation, but are also involved in a. o. the utilization of alternative carbon sources, the assembly of motility organs and the production of extracellular alginate. They differ considerably from the σ^70^ family members in sequence, promoter recognition and transcription initiation mechanism (Fig. [2D](#fig2){ref-type="fig"}) (Österberg, del Peso-Santos and Shingler [@bib309]; Shingler [@bib385]; Yang *et al.*[@bib448]; Glyde *et al.*[@bib155]). Yet, σ^54^ still binds overlapping sites on the core RNAP and competes with all other σ factors for core binding. Eσ^54^ holoenzymes interact with two nucleotide stretches centered around --12 and --24 (Doucleff *et al.*[@bib121]; Yang *et al.*[@bib448]). The latter is contacted in the major groove of the DNA by the recognition helix of a helix-turn-helix (HTH) motif that is present in the C-terminal domain of all σ^54^ proteins. This recognition helix contains nine highly conserved amino acids and is also referred to as the RpoN box. Eσ^54^ polymerases require an activator protein (also called bacterial enhancer binding protein) of the AAA^+^ family (ATPases associated with various cellular activities), many of which are part of two-component systems, and the energy of ATP hydrolysis to overcome the high energy barrier for open complex formation (Buck *et al.*[@bib51]; Reitzer and Schneider [@bib350]; Shingler [@bib385]; Bush and Dixon [@bib55]; Yang *et al.*[@bib448]; Zhang *et al.*[@bib453]; Glyde *et al.*[@bib155]). σ^54^-associated activators frequently act in conjunction with a DNA-bending protein such as IHF (integration host factor) or CRP/CAP (cyclic-AMP receptor protein/catabolite activator protein) that facilitate DNA looping between the upstream bound activator and the RNAP.

As indicated above, all σ factors present in a cell compete for binding to the unique core RNAP. Competition will depend on the affinity for the core and the concentration of free alternative σ factor in the cell. In general, the housekeeping σ factor has the highest affinity, and is the most abundant one in most growth conditions. However, in response to a certain stimulus the concentration of available, active alternative σ factor will increase and it will then successfully compete with and in part displace the housekeeping σ factor. Different strategies are used in nature to regulate the concentration and activity of alternative σ factors in the cell and their sequential production when they are involved in complex cascades of temporal gene expression. Such strategies operate at different levels and include the rate of synthesis (both transcription and translation) and proteolytic turnover, subcellular localization, sequestration and covalent modification (including limited proteolysis) (Fig. [3A and B](#fig3){ref-type="fig"}) (Campbell, Westblade and Darst [@bib59]; Österberg, del Peso-Santos and Shingler [@bib309]; Micevski and Dougan [@bib276]; Treviño-Quintanilla, Freyre-González and Martínez-Flores [@bib416]; Paget [@bib310]).

![Various mechanisms for regulation of σ factor activity. (**A**) Schematic representation of four mechanisms for regulation of σ-anti-σ factor activity involving stress-induced release of the σ factor from the inhibitory σ-anti-σ complex: regulated intramembrane proteolysis (RIP) of the anti-σ factor, partner switching, direct sensing and reduction of anti-σ concentration by secretion through the flagellar export system. Red colored symbols represent proteases. Orange colored symbols represent σ factors belonging to different groups (group 3 represented with three domains and group 4 (ECF) represented with two domains). A black colored symbol represents the cognate anti-σ factor. A blue colored ellipse with a P represents a phosphorylated anti-anti-σ factor. Zn surrounded by a green colored sphere represents a zinc atom. (**B**) Scheme summarizing different mechanisms used for regulation of σ factor activity in various bacteria. (**C**) Synthetic orthogonal gene expression system for *E. coli* based on the introduction of heterologous or artificial (hybrid) σ factors and their cognate specific promoters exhibiting no cross-talk, and fine-tuning of gene expression by use of promoter libraries with a broad range of transcription initiation frequencies without loss of orthogonality.](fuz001fig3){#fig3}

Some 'pro-σ' factors are activated by controlled proteolysis, whereby an autoinhibitory N-terminal extension is removed. Examples hereof are the activation of pro-σ^E^ and pro-σ^K^ in the mother cell compartment during starvation-induced sporulation of *B. subtilis* (Hofmeister *et al*. [@bib191]; Kroos *et al.*[@bib225]; Zhou and Kroos [@bib457]; Imamura *et al.*[@bib195]). However, post-translational control of the activity of alternative σ factors by anti-σ factors appears to be the most widespread mechanism for the regulation of σ factor activity. An anti-σ factor interacts with and stabilizes the cognate σ factor in a form that is incompatible with RNAP binding by concealing the key RNAP-binding determinants in domains 2 and 4 of the σ factor. Anti-σ factors are σ-specific and they frequently form an operon, sometimes also comprising a third gene encoding an anti-anti-σ factor. Release of the σ factor from the σ-anti-σ complex occurs in response to a signal recognized by the anti-σ itself or by additional components. Anti-σ factors are modular proteins, consisting of a σ-binding domain and a sensor/signaling domain that may respond to signals from within or outside the cell. Mechanisms known so far for the release of cytoplasmically located σ factors in response to signals are regulated proteolysis, partner switching and direct sensing (Fig. [3A](#fig3){ref-type="fig"}) (Österberg, del Peso-Santos and Shingler [@bib309]; Paget [@bib310]). Regulated intramembrane proteolysis (RIP) is the mechanism that is commonly used for signal transduction across membranes for the control of ECF σ factors in response to extracytoplasmic stimuli (Heinrich and Wiegert [@bib179]). RIP involves the sequential cleavage of a membrane-traversing anti-σ factor by two membrane-associated proteases (a 'site-1' and 'site-2' protease) resulting in the release of the cytoplasmic domain, which is bound to the σ factor. Release of the latter from this complex requires further degradation of the anti-σ factor by a cytoplasmic protease. In *E. coli*, RIP is used to control the release of σ^24^ (σ^E^) from RseA (the cognate anti-σ factor) in response to outer membrane dysfunction (e.g. upon heat shock), while in *B. subtilis* σ^W^ is released analogously from its *trans*-membrane anti-σ factor RsiW in response to cell envelope stress induced by antimicrobial peptides or agents (Ades [@bib1]; Heinrich and Wiegert [@bib179]).

'Partner switching' is a widespread mechanism that is used by anti-σ factors whose activity is countered by an anti-anti-σ factor that sequesters the anti-σ factor in response to a particular trigger (Fig. [3A](#fig3){ref-type="fig"}) (Herrou *et al.*[@bib185]). Some of these anti-anti-σ factors share structural similarities with their cognate σ factor, suggesting that they have evolved to be mimics (Francez-Charlot *et al.*[@bib139]). The *B. subtilis* group 3 σ factors σ^B^ and σ^F^ are two among the best-studied examples of partner switching. These systems consist of four key components: σ factor, anti-σ factor (a protein kinase), anti-anti-σ factor and a phosphatase complex. In absence of the trigger signal, the σ factor is kept in an inactive state by complex formation with the cognate anti-σ factor. However, the latter can alternatively bind to the non-phosphorylated anti-anti-σ factor, but anti-σ itself may phosphorylate the anti-anti-σ factor to antagonize this interaction. The phosphorylation status of the anti-anti-σ factor is thus crucial to the activity of the σ factor. In response to a trigger signal, a phosphatase will dephosphorylate the anti-anti-σ factor, thereby allowing it to bind anti-σ, which consequently results in the release of active σ (Hecker, Pané-Farré and Völker [@bib178]). In other instances, the anti-σ factor directly senses the signal, which induces a conformational change in the protein that results in release of the σ factor (Fig. [3A](#fig3){ref-type="fig"}). An example hereof is the σ^R^/RsrA system of *S. coelicolor* (Kang *et al.*[@bib209]). RsrA is a cysteine-rich protein, a member of the zinc-binding anti-σ domain (ZASD) family. It lacks membrane-spanning or extracytoplasmic domains. In response to oxidative stress, an intramolecular disulfide bond is formed that triggers the release of the zinc atom and the stabilization of an RsrA conformation that is unable to bind σ^R^ (Li *et al.*[@bib239]).

Regulation of anti-σ activity by secretion out of the cell is for instance used in control of the flagellum biogenesis in *Salmonella* Typhimurium (Smith and Hoover [@bib392]; Fitzgerald, Bonocora and Wade [@bib136]) (Fig. [3A](#fig3){ref-type="fig"}). Transcription of the late flagellar genes (encoding flagellin and chemotaxis functions) requires the alternative σ factor σ^28^ (σ^F^, FliA), which is kept in an inactive state by complex formation with its anti-σ factor FlgM (Aldridge *et al.*[@bib4]). Expression of the late flagellar genes by Eσ^F^ will therefore only occur when the concentration of FlgM has been sufficiently lowered by secretion through the flagellar export system. That is when the hook and basal body have already been assembled (Sainsi *et al.*[@bib368]).

Hereunder, we describe to some extent details of the regulation of *E. coli* σ^S^ synthesis and activity, and its competition for core RNAP binding with the housekeeping σ factor, as an example of the multi-layered character of bacterial regulatory mechanisms and their strong intertwinement. The concentration of σ^S^ in the cell is tightly regulated at the level of its synthesis (mainly but not exclusively post-transcriptionally) and degradation. Translation of the RpoS mRNA that is naturally repressed by the sequestration of the RBS in an extensive secondary structure present in the 5΄-untranslated region (5΄-UTR) is tightly regulated by the small non-coding RNAs (sRNAs) DsrA (osmotic shock), ArcZ (aerobic/anaerobic growth), RprA (low temperature stress) and OxyS (oxidative stress), each of which is expressed in response to a different stress condition (Repoila, Majdalani and Gottesman [@bib351]; Mika and Hengge [@bib277]). DsrA, RprA and ArcZ activate translation of the *rpoS* mRNA, whereas OxyS downregulates it. All four regulatory RNAs interact with the sRNA binding and chaperone protein Hfq (originally identified as a host factor required for replication of bacteriophage Qβ) that changes their structure. This conformational change has an impact on the interaction of DsrA, RprA and ArcZ with the 5΄-UTR and their susceptibility to degradation by RNase E, whereas OxyS appears to act through competition in the binding with Hfq (Moon and Gottesman [@bib286]; Henderson *et al.*[@bib182]). Furthermore, DsrA, ArcZ and RprA are also involved in transcriptional control of *rpoS*, where they suppress premature Rho-dependent transcription termination by inhibiting the binding of the transcription terminator protein and thus stimulate *rpoS* transcription during the transition to the stationary phase of growth (Sedlyarova *et al.*[@bib377]). See below for more information on mechanisms of regulation of mRNA stability, RNA-binding proteins and the action of small regulatory RNAs. RpoS transcription is also indirectly activated by the alarmone ppGpp. ppGpp in conjunction with DksA stimulates transcription of both the small regulatory RNA DsrA and the anti-adapter protein IraP (see below), which have a positive effect on RpoS activity (Girard *et al.*[@bib154]).

Ιn exponentially growing cells, σ^S^ is rapidly degraded by the ATP-dependent protease ClpXP in a RssB (regulator of σ^S^ B, alias SprE and MviA) dependent manner (Zhou and Gottesman [@bib458]; Zhou *et al.*[@bib459]). In contrast, its degradation is strongly reduced in the presence of three proteins (anti-adaptors) that act as inhibitors of RssB in response to (i) phosphate starvation (IraP), (ii) magnesium starvation (IraM) and (iii) DNA damage (IraD) (Bougdour, Wickner and Gottesman [@bib40]; Bougdour *et al.*[@bib39]; Battesti, Majdalani and Gottesman [@bib26], [@bib27]; Battesti *et al.*[@bib28], [@bib25]; Park *et al.*[@bib315]). Finally, at the transition from the exponential to the stationary growth phase the competition between the housekeeping and the stationary phase sigma factors for core RNAP binding is biased by sequestration of σ^70^ (sigma D) via two mechanisms: interaction with the Rsd protein (regulator of sigma D) (Patikoglou *et al.*[@bib317]; Hofmann, Wurm and Wagner [@bib190]; Park *et al.*[@bib316]) and binding to the small RNA molecule 6S that is abundantly produced in stationary phase and mimics the structure of an open promoter complex (Wilkomm and Hartmann [@bib436]; Wassarman [@bib433]; Lee *et al.*[@bib236]). This competition is further affected by the small protein Crl of *E. coli* and other γ-proteobacteria that exerts a positive effect on the assembly of the Eσ^S^ holoenzyme upon transition from the exponential to the stationary phase and in other stressful growth conditions (Banta *et al.*[@bib21]; Dudin, Lacour and Geiselmann [@bib123]).

Alternative σ factors for orthogonal expression of synthetic circuits {#sec1-4}
---------------------------------------------------------------------

The high degree of sequence conservation of the bacterial core RNAP, the specificity of σ factor-promoter recognition, the abundance and variety of naturally occurring alternative σ factors plus the possibility of generating artificial chimeric ones, combined with the observation that their activity can be modulated, turn alternative and heterologous sigma factors into outstanding candidates for applications in synthetic biology (Fig. [3C](#fig3){ref-type="fig"}). Furthermore, their small size, especially of the ECF family of σ factors, may contribute to limit the burden for the host cell to a minimum. Synthetic biology approaches have recently been applied for the improvement of industrial microbial strains for the production of both native and new-to-the-host products (Jullesson *et al.*[@bib204]; Cheon *et al.*[@bib89]; Pandey *et al.*[@bib313]). One major complication in such approaches is the occurrence of imbalances in the synthesis of pathway intermediates due to lack of adequate gene expression and regulation. This leads inevitably to high metabolic burden for the host organism, which, as a consequence, results in low production efficiencies/yields (Wu *et al.*[@bib445]). Dynamic pathway control and orthogonal transcription to maximally uncouple pathway expression from the host\'s metabolism may significantly contribute to restrict these negative effects. Rhodius *et al.* ([@bib352]) analyzed σ factors of the ECF family originating from various bacteria for orthogonality towards each other and towards the *E. coli* host, and demonstrated their potential for use in complex genetic circuits. Pinto *et al.* ([@bib334]) assembled ECF σ factors into regulatory cascades in *E. coli* and *B. subtilis* and demonstrated that such 'autonomous timer circuits' introduce a tunable time delay between inducer supply and target gene activation. Bervoets *et al.* ([@bib32]) showed orthogonality of various σ factors and their cognate naturally occurring promoters of different strengths, all originating from *B. subtilis* but belonging to different groups (groups 3 and 4), towards each other and towards the host (*E. coli*). Furthermore, they generated promoter libraries for three of these σ factors, σ^B^ (group 3, general stress response), σ^F^ (group 3, sporulation) and σ^W^ (group 4, ECF), by randomizing the spacer sequence (or part of it) connecting the --10 and --35 promoter elements. These promoter libraries cover a wide range of transcription initiation frequencies without loss of orthogonality. Together, these elements must allow the design of complex pathways, divided into modules driven by different σ factor--promoter pairs, in which the expression of each individual gene can be fine-tuned (Fig. [3C](#fig3){ref-type="fig"}). σ^W^ from *B. subtilis* and its cognate anti-σ factor (*rsiW*) were also used to demonstrate that ultrasensitivity from sequestration combined with positive feedback is sufficient to build a bistable switch (Chen and Arkin [@bib80]; see Box [2](#box2){ref-type="boxed-text"} for definition of bistable switch). Such bistable switches constitute the canonical solution for building memory units (Burrill and Silver [@bib54]). Similarly, Annunziata *et al.* ([@bib11]) used a σ factor originating from *P. aeruginosa* and its corresponding anti-σ factor in *E. coli* to generate an orthogonal multi-input system to control gene expression in a predictable manner. In addition to naturally occurring σ factor--promoter pairs, the modular architecture of σ factors with folded domains connected by less structured linkers allows the generation of chimeric σ factors with distinct promoter selectivity (Rhodius *et al.*[@bib352]). This observation further increases the capability of using multiple combinations of orthogonal expression systems in a single cell.

###### Logic gates and circuits

In analogy to electronics, logic gates in synthetic biology make use of physical elements and/or signals (e.g. gene regulatory elements, small effector molecules) to perform a logical operation dependent on inputs to produce a single output. Logic circuits are more complex as they contain combinations of several logic gates. Gates may be of different kinds and be used in different combinations (Fig. Box 2). A simple NOT gate has only one input and one output and the latter will only be produced in the absence of the former. In an AND gate configuration, the production of the output (X) relies on the simultaneous presence of at least two inputs (A and B). If only one of both inputs is present, no output will be generated. As a simple example, transcription of a gene generating the output (X) requires the presence of an activator protein (A) and an inducer molecule (B) that combines with the activator protein and enhances its DNA-binding affinity. Either one of them is not sufficient. In more complex AND gate configurations, the production of a single output may rely on more than two inputs. Inversely, a NAND gate (NOT-AND) is a logic gate that always leads to the production of output, except when all inputs are present. A NAND gate is thus complementary to the AND gate. In an OR gate configuration, the presence of either input A or B is sufficient to generate the output. Inversely, in a NOR gate configuration the generation of output is only ensured in the absence of both input signals, but inhibited by either one or both.

Toggle switch. In the context of synthetic biology and gene expression, a toggle switch corresponds to a bistable biological circuit that switches from one stable equilibrium state to another in a reversible manner depending on the input. It exhibits two exclusive states of gene expression (ON and OFF), but without other stable intermediate states.

Oscillator. In an oscillator system the level of output exhibits regular cycles around an unstable steady state. A crucial element in the generation of the oscillator behavior is the presence of an inhibitory feedback loop in gene expression in which an increase in the activity of one gene activates other genes of the circuit that ultimately will inhibit its synthesis. A second requisite of an oscillator is the presence of an in-built time delay that enables the activities of the respective genes in the circuit to fluctuate in regular cycles.

Resource allocator. A frequently encountered problem in synthetic biology and heterologous gene expression is the exhaustion of cellular resources (building blocks such as amino acids, nucleotides and energy) and basal gene expression elements (e.g. core RNAP, ribosomes). This will result in a metabolic burden and unexpected interferences between the host and circuit gene expression as core RNAP and free ribosome numbers may limit gene expression. One manner to avoid or at least reduce these risks consists in the uncoupling of heterologous gene expression from the host machinery via orthogonal transcription and/or translation and the introduction of a resource allocator that allows to control the allocation of resources between the host and the circuit genes. A resource allocator separates the regulation of the expression system (controllers) from the genes encoding the desired cellular functions (actuators). As an example, a controller that ensures the synthesis of a synthetic orthogonal 16S rRNA (that will assemble with other host-encoded ribosomal proteins and rRNA molecules into orthogonal ribosomes in competition with the endogeneous host 16S rRNA) may be combined with a transcriptional repressor that allows to adapt the amount of the orthogonal 16S rRNA produced in response to demands via a negative feedback loop (Darlington *et al.*[@bib105]). If the repressor is constitutively expressed at transcriptional level and translated by the orthogonal ribosome pool itself, then it will act as both a sensor and regulator of the free orthogonal ribosome pool. At low expression of the circuit genes, the ratio of orthogonal ribosomes/repressor mRNA is high and the repressor will be produced in high concentrations. As a consequence, the production of orthogonal 16S rRNA is low and only few ribosomal constituents are used to assemble orthogonal ribosomes. In contrast, when circuit genes are expressed at a higher level, the number of orthogonal ribosomes per regulator mRNA molecule decreases due to the competition with the circuit mRNAs and the repressor concentration in the cell will drop. As a consequence, the synthesis of orthogonal 16S rRNA will increase, as will the pool of cognate orthogonal ribosomes and circuit expression. Similarly the use of split T7 RNAPs in which each output of the controller (various RNAP fragments recognizing a cognate promoter sequence) combines with a common core RNAP fragment to express various gene circuits (each with a different promoter sequence) ensures that the total amount of heterologous RNAP will not cross a certain threshold imposed by the limited amount of available core fragment (the allocator) (Segall-Shapiro *et al.*[@bib378]).

![Various types of logic gates. A and B represent inputs (with absence of input indicated with 0 and presence with 1), and X the potential output.](fuz001ufig1){#fig3a}

A condition that should absolutely be guaranteed in the application of σ factors (and all other strategies based on single subunit RNAPs or transcription factors, as explained below) for orthogonal (heterologous) gene expression is that their expression in the host organism does not lead to an important burden or growth inhibitory effect (Lynch and Marinov [@bib253]). Even though most tested sigma factors in the above cited examples meet this criterion, this was not always the case (Bervoets *et al.*[@bib32]). To reduce the expression level of the heterologous σ factor(s) (and the accompanying burden), and for reasons of stability of recombinant strain, it is advisable to integrate the corresponding gene into the host genome by generating a single copy knock-in. Depending on the application, σ factor expression may then be driven by a constitutive promoter of well-defined strength (naturally occurring or synthetic), an inducible promoter that can be activated by administering an external stimulus or be linked to an intracellularly produced signal, or be co-transcribed as a polycistronic mRNA with well-defined expression profile (De Paepe *et al.*[@bib112]; Bervoets *et al.*[@bib32]). In such a setup, alternative σ factor--promoter pairs used to drive heterologous gene expression in an orthogonal manner may be combined with well-characterized classical allosteric DNA-binding transcription regulators (or other regulatory mechanisms, see below) to modulate σ factor expression.

In the general context of burden, it is worth mentioning that Ceroni *et al.* ([@bib69]) identified the major transcriptional changes occurring in *E. coli* host cells upon induction of heterologous gene expression. Irrespective of the nature of the heterologously expressed protein, these appeared to consist essentially of heat-shock response-activated genes. Based on this observation, the authors developed a burden-driven feedback control mechanism that adjusts the expression of the heterologous construct in response to burden. This system relies on the knowledge of the heat-shock response and a CRISPR/dCas9-based (clustered regularly interspaced short palindromic repeats and Crispr-associated proteins) feedback regulation system to specifically target the heterologous gene construct. dCas9 is a 'dead' variant of the Cas9 nuclease, which in association with a small guide RNA (sgRNA) still selectively binds specific DNA sequences but no longer cleaves the DNA (Sander and Joung [@bib371]).

Another strategy to generate orthogonal gene expression by attracting the RNAP to specific promoters relies on the exploitation of the strong promoter selectivity exhibited by single subunit RNAPs, generally of viral origin, of which T7 polymerase is certainly the best-characterized and most widely applied example. The system is renowned for its simplicity and transcriptional activity: the polymerase is very compact and the T7 promoter that is orthogonal in many organisms consists of 17 bp only, and the enzyme is highly processive and functions in a wide variety of hosts (reviewed in Borkotoky and Murali [@bib38]). This high processivity has however a drawback since in uncontrolled conditions expression from a T7 promoter may rapidly exhaust the cellular resources resulting in a severe burden and even cell death. Recently applied strategies to reduce this strong activity are the introduction of a stop codon in the T7 RNAP that is then translated under the control of a nonsense suppressor (Angius *et al.*[@bib10]), the expression of an antisense gene cassette and modulation of translation of the T7 RNAP encoding mRNA with a synthetic RBS (Liang *et al.*[@bib240]), or the construction of a self-limiting T7 RNAP expression system (Kar and Ellington [@bib210]).

In the most classical and commercially available application, T7 RNAP is used for the isopropyl-β-[d]{.smallcaps}-1-thiogalactopyranoside (IPTG)-induced overproduction of recombinant proteins from a T7-specific orthogonal promoter under control of the *lac* operator/repressor in *E. coli*. However, the system was further engineered to allow the combination of multiple orthogonal expression systems in a single cell. Thus, mutants of the polymerase with a different DNA sequence specificity have been produced to generate orthogonal polymerase--promoter pairs that allow for modular control of multiple pathways (Temme *et al.*[@bib412]; Meyer, Ellefson and Ellington [@bib274]). Orthogonality was achieved by swapping the DNA-binding loop of T7 RNAP with homologous sequences mined from sequence databases. Furthermore, split variants of the T7 RNAP consisting of two, three or four parts have been used to create transcriptional AND gates for integration in genetic circuitry as well as a 'resource allocator' (Shis and Bennett [@bib386]; Segall-Shapiro *et al.*[@bib378]) (see Box [2](#box2){ref-type="boxed-text"} for definition of gates and resource allocator). In these applications, the generation of a functional enzyme relies on the *in vivo* assembly of different polymerase fragments in various combinations. These fragments may be produced from different host-specific promoters under the control of distinct regulatory proteins and influenced (induced/repressed) by different effector molecules for the construction of logic gates (Iyer *et al.*[@bib197]). To a certain extent, such an assembly strategy mimicks the association of the bacterial RNAP core with different σ factors to generate promoter specificity.

Transcriptional regulation by DNA-binding transcription factors: repression and activation {#sec1-5}
------------------------------------------------------------------------------------------

The transcription initiation frequency of the vast majority of bacterial genes and operons is at least in part regulated (negatively and/or positively) by accessory *trans*-acting proteins that bind to specific DNA sequences, generally near to or even overlapping the binding site for RNAP (Fig. [4](#fig4){ref-type="fig"}). The ensemble of all genes regulated by the same transcription factor (TF) and dispersed over the chromosome is called a regulon, as coined by Maas and Clark ([@bib256]). Bacterial DNA-binding TFs mostly use an HTH or less frequently a β-ribbon motif (ribbon-helix-helix) to bind specific DNA sequences (Nelson [@bib295]; Schreiter and Drennan [@bib374]). The typical bacterial HTH motif is about 20 amino acids (aa) long and comprises two α-helices (called orientation and recognition helix) separated by a short (3--4 aa) turn (Aravind *et al.*[@bib13]). The orientation helix interacts essentially with the sugar-phosphate backbone, whereas the recognition helix establishes sequence-specific interactions. These consist mainly of hydrogen bonds with base-specific groups at the bottom of the major groove and hydrophobic interactions with the methyl group of thymine to unambiguously distinguish the four possible Watson--Crick bps and short specific target sequences within the millions of bps of a bacterial genome (Choo and Klug [@bib93]; Nadassy, Wodak and Janin [@bib294]; Cheng *et al.*[@bib86]; Pan *et al.*[@bib312]). Bacterial HTH proteins generally bind as dimers (or higher oligomeric forms) to imperfect palindromes and interact with two or more major groove segments aligned on one face of the helix. Frequently they also bear an additional DNA-binding element, such as an N-terminal extension (Feng, Johnson and Dickerson [@bib133]), a wing (wHTH) (Brennan [@bib46]) or a hinge helix, as in the LacI/PurR family (Schumacher *et al.*[@bib375]) that further enhances target selectivity and binding affinity. Wings, consisting of antiparallel β-strands, and hinge helices generally interact with the minor groove segment located in between and on the same face as the major groove segments contacted by the recognition helices, whereas N-terminal extensions may interact with the opposite face of the DNA.

![Regulation of promoter activity by DNA-binding transcription factors. (**A**) Negative regulation by repressors (red colored symbols). Various possibilities are depicted. In repression by steric hindrance, binding of the repressor in overlap with the RNAP-binding site generates a direct competition in the binding between the regulator and the RNAP. In the roadblock model, binding of the repressor downstream of the promoter element physically inhibits the further progression of the RNAP. Pronounced DNA deformation may result from the binding of repressor proteins upstream and downstream of the promoter making the latter unsuitable for RNAP binding. Negative regulation by anti-activation may result from the mutually exclusive binding of a repressor and an activator to overlapping sites (not shown) or, as shown, from the interference of the repressor with the stimulating effect of the activator on RNAP recruitment. Finally, promoter clearance may be inhibited by a repressor protein that makes strong contacts with both DNA and RNAP thus inhibiting RNAP movement. (**B**) Stimulation of transcription initiation by activator proteins (green colored symbols). In class I activation, the activator binds at variable distances upstream of the --35 promoter element and makes protein--protein contacts with one or two σ-CTDs, thereby stimulating RNAP recruitment. In class II activation, the regulator binds in overlap with the promoter and makes contacts with α-NTD or σ, or with both. Some activators bind in between the --10 and --35 sequences of promoters with a suboptimal spacing and stimulate promoter activity by untwisting the DNA helix, thus generating a better alignment of the promoter elements for RNAP binding. σ^54^-dependent promoters require activators of the AAA^+^ family and the energy of ATP hydrolysis. They generally bind upstream of the promoter elements and act in conjunction with a DNA-bending protein (purple sphere) to facilitate their contact with the RNAP.](fuz001fig4){#fig4}

A TF that exerts a negative effect on the transcription initiation frequency of a target gene is called a repressor. Repressors can operate through many different mechanisms or combinations thereof, including steric hindrance of RNAP binding or inhibition of later stages of transcription initiation and elongation, local DNA structure alterations (bending, wrapping, looping, twisting) and counteraction of another activating TF (anti-activation) (Fig. [4A](#fig4){ref-type="fig"}). Some TFs bind to operator sequences partially overlapping the conserved --10 or --35 promoter element, thereby sterically interfering with RNAP binding. This is how *E. coli* ArgR (arginine repressor) represses the P2 promoter of the *carAB* operon (encoding carbamoylphosphate synthase) (Charlier *et al.*[@bib79]). Others function as a downstream bound 'roadblock' for transcription elongation, as does PurR (purine repressor) in regulation of the *purB* promoter (encoding adenylosuccinate lyase) (He and Zalkin [@bib177]). Repressors may also inhibit transcription by competing with α-CTD for binding a UP element (Quinones *et al.*[@bib341]) or bind at an even larger distance from the promoter. For example, GalR (galactose repressor) binding to two distally located operators of the *galETK* operon induces DNA looping, which prevents binding of RNAP (Swint-Kruse and Matthews [@bib407]). DNA looping may be facilitated by a DNA-bending protein such as IHF (Moitoso de Vargas, Kim and Landy [@bib283]). DNA wrapping around hexameric PepA (aminopeptidase A, a trigger enzyme) generates a positive toroidal supercoil and represses transcription initiation at the P1 promoter of the *E. coli carAB* operon (Nguyen Le Minh, Nadal and Charlier [@bib298]). Repression can also be accomplished by a TF acting as 'anti-activator', either by directly competing with the activator for binding to overlapping targets or by blocking the activating signal. An example of the latter is CytR (cytidine repressor) that interacts simultaneously with its operator DNA and the activator protein CRP/CAP, thereby counteracting the activity of the latter (Valentin-Hansen, Søgaard-Andersen and Pedersen [@bib424]). Finally, repression may result from direct interaction of the TF with RNAP, such as protein p4 of bacteriophage Φ29 that binds both α-CTD and the DNA upstream of the RNAP-binding site, hence preventing promoter clearance (Monsalve *et al.*[@bib285]). Similarly, lysine-bound ArgP stimulates RNAP binding to the *E. coli argO* (arginine outward) promoter but sequesters the polymerase in a non-productive complex, whereas arginine-bound ArgP makes slightly different DNA contacts and activates *argO* transcription (Laishram and Gowrishankar [@bib229]; Nguyen Le Minh *et al.*[@bib299]). Finally, protein Rv1222 of *Mycobacterium tuberculosis* that interacts with both RNAP and DNA inhibits transcription by anchoring the RNAP onto DNA (Rudra *et al.*[@bib363]). The positively charged C-terminal tail of the Rv1222 interacts with DNA and slows down the RNAP movement during transcription elongation. As this interaction with DNA is electrostatic and not sequence dependent, Rv1222 could in principle inhibit transcription from any promoter.

TFs that stimulate transcription are called activators. Activation of the *E. coli* arabinose operon by AraC and activation of its *lac* operon by CRP/CAP were the very first reported cases of bacterial transcription activation (Englesberg *et al.*[@bib127]; Zubay, Schwartz and Beckwith [@bib460]). Activators generally stimulate transcription of promoters that have suboptimal promoter sequences and require an activator protein to stimulate RNAP recruitment. They can act by direct activation through different mechanisms: class I and class II activation, or activation by remodeling of the promoter DNA (Fig. [4B](#fig4){ref-type="fig"}) (Lee, Minchin and Busby [@bib235]). In class I activation, the activator protein binds upstream of the promoter and recruits RNAP by interacting directly with the α-CTD of the polymerase. This is how CRP, the very first transcription activator protein to have been purified, works at some promoters such as the *lac* operon (Benoff *et al.*[@bib30]; Lawson *et al.*[@bib233]; Shimada *et al.*[@bib384]). Thanks to the length and flexibility of the linker connecting α-CTD to α-NTD of the core polymerase, class I activators may bind at different distances upstream of the promoter. In class II activation, the TF binds to a site overlapping the --35 promoter element and forms direct interactions with domain 4 of σ, with α-NTD or with both (Lee, Minchin and Busby [@bib235]; Feng, Zhang and Ebright [@bib134]). For class II activators, there is very little flexibility in their position on the DNA. An example is autoactivation of bacteriophage λ *cI* transcription initiation from the λ P~RM~ promoter for repression maintenance (Li, Moyle and Susskind [@bib238]). It is worth noticing that class I and class II activators may function together on the same promoter, and that such an arrangement allows for promoter stimulation that is co-dependent on two distinct signals. Furthermore, some activators such as CRP may function as both class I and class II activators, dependent on the architecture of the promoter-operator region (Lawson *et al.*[@bib233]). A third activation mechanism consists of promoter remodeling, usually of promoters with a suboptimal spacing between the --10 and --35 promoter elements, resulting in their misalignment on the helical surface with respect to the interacting domains of σ. The best-studied examples involve members of the MerR family of metal-binding transcription regulators (Brown *et al.*[@bib49]). In absence of the effector molecule MerR (mercury resistance regulator) binds to a region in between the --10 and --35 promoter elements and bends the DNA away from the polymerase; hence, unliganded MerR acts as a repressor. However, from the same position Hg^++^-bound MerR untwists the 19 bp long linker region, resulting in a better alignment of the promoter elements, hence facilitating RNAP binding. MerR is thus both a repressor (unliganded) and an activator (liganded) (Heltzel *et al.*[@bib181]; Ansari, Bradner and O'Halloran [@bib12]).

The affinity of DNA-binding TFs (repressors and activators) for particular target sequences is frequently modulated by reversible interaction with one or more small molecules or chemical modifications. They are allosteric proteins that bind inducers and/or co-repressors, or undergo reversible covalent modifications including phosphorylation-dephosphorylation (two-component and phospho-relay systems) or oxidation-reduction (disulfide bond formation) that affect their DNA-binding potential. As an example, binding of allolactose or the artificial inducer IPTG to the C-terminal domain of tetrameric *E. coli* LacI (lactose operon regulator) or of uracil to dimeric RutR (regulator of pyrimidine utilization) triggers a conformational change that lowers the DNA-binding affinity of the N-terminal domain of the repressor (Matthews and Nichols [@bib269]; Nguyen Ple *et al.*[@bib300]; Nguyen Le Minh *et al.*[@bib297]). In contrast, binding of c-AMP (inducer) to CRP/CAP or of arginine (co-repressor) to hexameric *E. coli* ArgR strongly enhances the binding affinity and sequence specificity of these regulators for their targets (Charlier *et al.*[@bib78]; Mukhopadhyay, Sur and Parrack [@bib289]; Szwajkajzer *et al.*[@bib408]; Lawson *et al.*[@bib233]). Interestingly, arginine binding to hexameric ArgR shows negative cooperativity, whereby binding of the first arginine molecule results in a 100-fold reduction in the affinity of the five remaining sites (Jin *et al.*[@bib202]; Strawn *et al.*[@bib405]; Pandley *et al.*[@bib314]). Positive cooperativity in effector binding lowers the concentration of effector able to act as a switch for the conversion of apo- to holoregulator. In contrast, negative cooperativity ensures buffering capacity against changes in effector concentration. Some allosteric regulators bind more than one effector molecule and these may exert opposite effects on the regulatory outcome (transforming a repressor into an activator and vice versa) on the same or distinct promoters, as observed for instance for *E. coli* TyrR (tyrosine repressor) and ArgP (regulator of arginine export and other genes) (Pittard, Camakaris and Yang [@bib335]; Laishram and Gowrishankar [@bib229]; Nguyen Le Minh *et al.*[@bib299]). Some TFs are therefore very versatile (see also below for more details on TyrR action).

Some DNA-binding TFs need a partner signal-sensing protein to exert a regulatory effect. This is particularly so for regulators whose activity depends on their phosphorylation status. Two-component systems consist of a sensor kinase, generally an inner membrane-bound histidine kinase that upon sensing a particular signal (mostly a physicochemical stress) performs autophosphorylation of a specific histidine residue situated on the cytoplasmic surface of the protein, and subsequently transmits the phosphoryl group to a conserved aspartate residue of the cognate response regulator (Egger, Park and Inouye [@bib126]). The vast majority of activating response regulators is active only when phosphorylated, but there are exceptions (Gao, Mack and Stock [@bib148]). A typical example of transcriptional regulation by a two-component system is regulation of the outer membrane proteins OmpC and OmpF by EnvZ (senor kinase) and OmpR (response regulator) in response to the osmolarity of the environment (Yoshida *et al.*[@bib449]). Phosphorylated OmpR (OmpR-P) functions as an activator for *ompC* but as a repressor of *ompF*. OmpR-P is also an activator of *micF*, encoding a small regulatory antisense RNA that negatively affects translation of *ompF* mRNA by sequestering the RBS site in a double-stranded RNA structure (Coyer *et al.*[@bib99]). This again illustrates the combined use of different regulatory mechanisms (TF and sRNA) and regulation at different stages (initiation of transcription and translation) in the flow of genetic information.

Phopho-relay systems are more complex versions of two-component systems as they contain more interacting partners. As in two-component systems, the initially autophosphorylated sensor kinase transfers the phosphoryl group from a phosphorylated histidine residue to an aspartate containing protein (a response regulator lacking an output domain). Then, the phosphoryl group is transferred to a histidine containing phosphotransfer protein, which in turn interacts with an aspartate containing protein. This transfer may occur a variable number of times, depending on the system, till the phosphoryl group is eventually transmitted to a terminal response regulator that directly affects the transcription initiation frequency. The advantages of multiple phospho-transfers are that (i) they allow the integration of different signals in a regulatory cascade with the use of different kinases and so-called connector proteins that may block phosphorylation reactions or dephosphorylate particular phosphotransfer proteins of the cascade, and (ii) allow interactions between different two-component systems (Bijlsma and Groisman [@bib34]; Mitrophanov and Groisman [@bib280]). A well-characterized example of phospho-relay is the initiation of spore formation with *B. subtilis*. Sporulation is initiated with the phosphorylation of Spo0F by one of five related kinases (KinA, KinB, KinC, KinD, KinE) that respond to different signals. Then, Spo0F-P passes on the phosphoryl group to Spo0B, which in turn transfers it to Spo0A, the key activator of sporulation (Burbulys, Trach and Hoch [@bib52]). Two-component systems and phospho-relay cascades are abundantly present in Gram-negative (*E. coli* has about 30, *P. aeruginosa* 64, the highest number of all sequenced bacterial genomes) and Gram-positive bacteria (*B. subtilis* has 34) and are involved in the regulation of a variety of critical physiological functions including sporulation, natural competence, antibiotic and heavy metal resistance, transition to stationary phase, osmoregulation, etc. (Fabret, Feher and Hoch [@bib131]; Rodrigue *et al.*[@bib358]). For more details on two-component systems, their signaling mechanism and partner specificity, the reader is referred to Mitrophanov and Groisman ([@bib280]), Casino, Rubio and Marina ([@bib64], [@bib65]), Olivera, Ugalde and Martínez-Antonio ([@bib308]). Recently it became clear that bacteria also encode many orphan regulators that lack cognate kinases, and new roles have been identified for unphosphorylated response regulators (Desai and Kenney [@bib113]).

Another signaling mechanism consists in the oxidation/reduction of regulatory proteins (Sevilla *et al.*[@bib382]). As an example, modulation of the regulatory properties of OxyR, the H~2~O~2~-responsive sensor of oxidative stress and member of the LysR-type family of transcriptional regulators (LTTR), occurs through oxidation of two conserved cysteine residues and the formation of an intramolecular disulfide (Zheng, Aslund and Storz [@bib454]; Kim *et al.*[@bib217]). Oxidation of the regulator alters its DNA-binding affinity and local DNA contacts according to the sliding dimer mechanism (Toledano *et al.*[@bib415]; Teramoto, Inui and Yukawa [@bib413]) that is frequently observed for members of the very large LTTR family (Maddocks and Oyston [@bib262]). Noteworthy, OxyR functions as an activator of defensive genes such as catalase in *E. coli* and *P. aeruginosa*, but as a repressor in *Corynebacterium glutamicum* (Zheng *et al.*[@bib455]; Wei *et al.*[@bib434]; Teramoto, Inui and Yukawa [@bib413]; Pedre *et al.*[@bib320]).

From the above description, it is already evident that TFs may use very different molecular strategies to influence the transcription initiation frequency. Furthermore, the versatility of bacterial TFs is underscored by the observation that a single regulatory protein may bind different effector molecules and have a different effect on the same or different target genes, dependent on the ligand. This is illustrated here with *E. coli* Lrp (leucine responsive regulatory protein), the prototype of a superfamily of global regulators, also called feast/famine regulators, which are abundantly present in bacteria and archaea as well (Calvo and Matthews [@bib56]; Newman and Lin [@bib296]; Brinkman *et al.*[@bib48]; Kawashima *et al.*[@bib211]; Peeters and Charlier [@bib322]; Song *et al.*[@bib395]). *Escherichia coli* Lrp, the best-studied member of the family, frequently exerts a regulatory effect on top of a more specific regulator (enhancing or counteracting its effect) or acts in conjunction with other global gene regulators and genome organizers, such as IHF, H-NS (histone-like nucleoid structuring protein), HU (heat unstable nucleoid protein), Fis (factor for inversion stimulation), CRP and ArgP (alias IciA, inhibitor of *oriC* initiation) to coordinate the global cellular response (about 10% of all genes) upon transitions between rich and lean nutritional conditions (Azam and Ishihama [@bib17]). The ensemble of genes/operons submitted to regulation by such a global regulator is coined a modulon. Besides leucine, its major effector molecule, Lrp is also responsive to a varying extent to methionine, isoleucine, histidine and threonine (Hart and Blumenthal [@bib174]). The molecular strategies employed by Lrp are diverse (van der Woude, Braaten and Low [@bib426]; Kaltenbach, Braaten and Low [@bib207]; Zhi, Mathew and Freundlich [@bib456]; Pul *et al.*[@bib338]; Stoebel, Free and Dorman [@bib404]; Peeters *et al.*[@bib323]). Depending on the specific target, Lrp may act as a repressor or an activator, and in both instances the regulatory outcome may be insensitive, enhanced or reduced in presence of the effector (Hung, Baldi and Hatfield [@bib194]; Tani *et al.*[@bib411]; Cho *et al.*[@bib90]). These combinations have been described as the concerted (the effect of the regulator is potentiated by the effector) and reciprocal (effector and regulator have opposite effects) manner. Effector binding influences the oligomeric state of the protein that frequently binds (cooperatively) to multiple degenerated binding sites in an operator (Chen, Rosner and Calvo [@bib84]; Chen and Calvo [@bib82]; Chen, Iannolo and Calvo [@bib83]) (frequently overlapping the binding site of another TF) and induces DNA bending (Wang and Calvo [@bib432]).

*Escherichia coli* TyrR is another example of a versatile TF that may act as both repressor and activator and binds several effector molecules (tyrosine, phenylalanine, ATP) that affect the oligomeric state of the protein and the affinity for different target operator sites that are generally composite and consist of strong (high affinity) and weak (low affinity) binding sites (boxes). Unliganded dimeric TyrR binds to strong boxes only, whereas hexameric TyrR formed by self-association upon binding of tyrosine and ATP binds simultaneously to strong and weak boxes. The regulatory outcome will thus depend on the nature of the effector present, composition of the target site and position of the boxes with respect to the promoter elements. As a result, all TyrR regulon members are regulated in a different manner and a single promoter may be regulated differently depending on the ligand availability (reviewed in Pittard, Camakaris and Yang [@bib335]). As an example, *tyrP* transcription is slightly repressed by dimeric apo-TyrR, activated by dimeric phenylalanine-bound TyrR, and strongly repressed by hexameric tyrosine-bound TyrR (Yang *et al.*[@bib447]).

Many control regions bear binding sites for several repressors and/or activators allowing the integration of different signals, resulting in a coordinated, adapted and fine-tuned response. The various regulators may then act independent of each other, in a concerted manner or, in contrast, in a competitive manner. An example is the regulation of the *E. coli carAB* operon, encoding the sole carbamoylphosphate synthase that ensures the synthesis of all carbamoylphosphate in the cell, a precursor common to the *de novo* synthesis of arginine and pyrimidine nucleotides. In *E. coli* and *S.* Typhimurium, the *carAB* operon is transcribed from two promoters in tandem (Piette *et al.*[@bib333]; Kilstrup *et al.*[@bib216]). Initiation at the downstream promoter P2 is essentially repressed by arginine-bound hexameric ArgR that sterically interferes with binding of RNAP at P2 but is unable to block an RNAP molecule initiated at promoter P1, 67 nt more upstream (Charlier *et al.*[@bib79]; Wang, Glansdorff and Charlier [@bib431]). Regulation of P1 is complex and involves an interplay between the DNA-binding TFs PurR, RutR and IHF, and the hexameric trigger enzymes (proteins with catalytic activity also exerting a gene regulatory function; Commichau and Stülke [@bib94]) PepA (Aminopeptidase A) and PyrH (UMP-kinase). IHF-induced DNA bending and PepA-induced wrapping of the P1 control region play a major role in the elaboration of higher order nucleo-protein complexes (Minh *et al.*[@bib279]). IHF stimulates P1 activity in minimal medium but potentiates pyrimidine-dependent repression and affects the methylation status of the control region (Charlier *et al.*[@bib77], [@bib73], [@bib71]). RutR stimulates P1 activity in a uracil-sensitive manner (Shimada *et al.*[@bib384a]; Nguyen Ple *et al.*[@bib300]; Nguyen Le Minh *et al.*[@bib297]). PepA acts as a strong repressor of P1 activity (Charlier *et al.*[@bib72]; Nguyen Le Minh, Nadal and Charlier [@bib298]). It is required for the PurR-mediated purine-specific repression (Devroede *et al.*[@bib117]) but abolishes the stimulatory effect of unliganded RutR (Nguyen Le Minh, Nadal and Charlier [@bib298]). Finally, PepA also appears to be involved in the recruitment of PyrH to the P1 control region by protein--protein contacts (Kholti *et al.*[@bib214]; Charlier *et al.*[@bib74], Marco-Marín, Escamilla-Honrubia and Rubio [@bib266]). Besides this complex regulation by multiple bona fide TFs and trigger enzymes, P1 is subject to stringent control (ppGpp) (Bouvier, Patte and Stragier [@bib43]) and UTP-dependent RNAP stuttering (Han and Turnbough [@bib171]) (see below for the mechanism of RNAP stuttering). For a complete overview of *carAB* regulation, see Charlier, Nguyen Le Minh and Roovers ([@bib75]).

In this context of regulation of pyrimidine nucleotide biosynthesis, it is worth noticing that different bacteria may exhibit a completely different genomic organization of the pathway and use different regulatory strategies for its control. Whereas in *E. coli* the pyrimidine biosynthesis genes are dispersed all over the chromosome and regulated by distinct mechanisms (or combinations thereof) including activation and repression by TFs, stringent control, UTP-dependent stuttering, transcriptional and translational attenuation, and regulation of mRNA decay, they are grouped in an operon in *B. subtilis* and mainly regulated by the RNA-binding protein PyrR (reviewed in Turnbough and Switzer [@bib420]). Interestingly, *B. subtilis pyrR* is the result of a gene duplication (*upp*) followed by functional divergence, but the regulator still exhibits residual uracil phosphoribosyltransferase activity.

Besides regulation by specific TFs, bacterial gene expression is also influenced on a genome wide scale by nucleoid-associated proteins (NAPs) that are not only involved in genome structuring but also display gene silencing and anti-gene silencing activities (Dillon and Dorman [@bib119]; Seshasayee [@bib381]; Dame and Tark-Dame [@bib102]). Thus, DNA bridges generated upon binding of H-NS (Dame, Wyman and Goosen [@bib103]; Amit, Oppenheim and Stavans [@bib7]) have the potential to trap or exclude RNAP and silence gene expression (Dame *et al.*[@bib104]; Dame, Noom and Wuite [@bib101]). Consequently, H-NS that is present at a constant level per chromosome throughout the cell cycle appears to be a universal repressor (Free and Dorman [@bib141]). This negative action of H-NS may be locally counteracted by other NAPs with DNA bending or wrapping activity, thus interfering with DNA bridge formation. This is the case for HU that has DNA-bending activity and is considered as a regulator of DNA flexibility (Luijsterburg *et al.*[@bib252]). HU binds DNA non-specifically but preferentially interacts with distorted DNA segments such as prebend DNA and four-way junctions (Castaing *et al.*[@bib66]; Dey, Nagaraja and Ramakumar [@bib118]). HU also directly interacts with topoisomerase I, leading to differences in DNA superhelicity, which in turn affect gene expression (Broyles and Pettijohn [@bib50]; Oberto *et al.*[@bib307]; Dorman [@bib120]). Furthermore, some NAPs such as IHF, Fis, Lrp and ArgP that equally bend DNA and may counteract H-NS-mediated silencing exhibit moderate sequence specificity and may act as specific regulators (Charlier *et al.*[@bib77]; Rice *et al.*[@bib353]; Arfin *et al.*[@bib14]; Hung, Baldi and Hatfield [@bib194]; Swinger and Rice [@bib406]; Bradley *et al.*[@bib44]; Peeters *et al.*[@bib323]; Singh and Seshasayee [@bib388]; Skoko *et al.*[@bib390]; Cho *et al.*[@bib92]; Dey, Nagaraja and Ramakumar [@bib118]; Nguyen Le Minh *et al.*[@bib299]). Hence, the boundary between conventional transcriptional activators and NAPs is becoming increasingly blurred.

Potential of allosteric DNA-binding TFs and two-component systems in synthetic biology {#sec1-6}
--------------------------------------------------------------------------------------

The regulatory potential of well-characterized allosteric DNA-binding TFs and two-component systems, and their sequence-specific interaction with particular target sequences on the DNA are appealing properties for their exploitation in synthetic biology as they may be further rewired to create novel regulatory topologies. Bacteria encode a multitude of transcriptional regulators but only few have been exploited up to date in synthetic biology. Among these, LacI, AraC and TetR are the most frequently used ones for the fine-tuned regulation and induction of gene expression and the assembly of bistable switches, oscillators and logic gates (see Box [2](#box2){ref-type="boxed-text"} for definitions) (Fig. [5A](#fig5){ref-type="fig"}) (Gardner, Cantor and Colins [@bib149]; Bertram and Hillen [@bib31]; Khalil and Collins [@bib213]; Shis *et al.*[@bib387]; Cheng *et al.*[@bib88]; Chen *et al.*[@bib85]). In an attempt to increase the possibility of generating more complex circuits, Stanton *et al.* ([@bib401]) generated an orthogonal set of TetR-family repressor/operator combinations by part mining from bacterial genomes. Zeng *et al.* ([@bib451]) constructed a transcriptional AND gate based on split-ligand-inducible TetR proteins and adapted it for use as a protein aggregation sensor in which the larger TetR fragment serves as a detector whereas the smaller fragment is fused to an aggregation-prone protein that serves as a sensor of the aggregation status. In this system, the expression of a split-TetR-repressible fluorescent reporter gene is proportional to protein aggregation. Two-component systems have been used for the generation of biosensors sensing heavy metals and organic pollutants, or were further engineered into chimeric systems for the detection of novel compounds (Ravikumar *et al.*[@bib347]). To be applicable in synthetic biology, gene expression driven and controlled by TFs must exhibit the correct ON and OFF state characteristics and present a sufficiently large dynamic range. These conditions are not necessarily fulfilled with naturally occurring regulatory systems as they may be leaky and not attain sufficiently high expression levels upon derepression or activation required for specific applications. Tuning of this dynamic range in an attempt to obtain desired ON and OFF states was performed by Chen *et al.* ([@bib85]), who constructed a library of promoters covering a spectrum of dynamic ranges by assembling sets of AraC- and LasR-regulated promoters containing the --10 and --35 elements from various promoters, naturally occurring in *E. coli* or synthetic ones. Besides chemically inducible systems genetically engineered light-sensitive sensors might be advantageously used for the control of gene expression (reviewed in Camsund, Lindblad and Jaramillo [@bib60]). Frangipane *et al.* ([@bib140]) have genetically engineered *E. coli* with proteorhodopsin and were able to influence the movement of these bacteria in a light-controlled manner allowing the generation of complex shapes starting from a homogeneous population of freely swimming bacteria. Similarly, they successfully reproduced grayscale density images. Light induction has a number of advantages as no chemicals have to be used, its application from outside the reactor is transient and non-invasive, light of different wavelengths is easy to produce and cheap, and as there exist biological sensors responding to different parts of the visible spectrum this opens the possibility of simultaneous multichromatic control of several transcription units. Furthermore, light may serve as an interface between biological systems and computing.

![Theoretical examples of synthetic circuit building for orthogonal gene expression. (**A**) Hypothetical example of a three-level circuit for orthogonal gene expression combining various gates and integrating multiple signals. The modules on the left represent two AND gates in which inputs I~1~ and I~2~ allow the synthesis of a TF and its chaperone (green and salmon colored symbols) that will activate the production of the output O~1~ (magenta colored), whereas inputs I~3~ and I~4~ ensure the synthesis of the two parts of a split TF (or alternatively of a split single subunit RNAP) (purple and light blue colored symbols), which will result in the production of output O~2~ (taupe colored). O~1~ and O~2~ form a hetero-oligomeric TF that will allow the production O~3~, an orthogonal alternative σ factor (orange colored) that eventually will ensure the synthesis of the final outcome O~4~. However, this will only occur in the absence of the inputs I~5~ and I~6~. In the presence of I~5~, the formation of the hetero-oligomeric activator (O~1~-O~2~) will be inhibited by sequestration of O~2~ upon binding with an alternative binding partner (dark blue colored), whereas in the presence of I~6~ the orthogonal σ factor will be sequestered by its cognate anti-σ factor (black colored). (**B**) Orthogonal gene expression based on toehold switches with co-localized RNA sensing and output modules. In toehold switches, the RBS is not accessible for ribosome binding, unless the RNA secondary structure is disrupted by interaction of the mRNA with a complementary synthetic sRNA. Importantly, and in contrast to other regulatory mechanisms operating at translational level (see Figs [6](#fig6){ref-type="fig"}--[8](#fig8){ref-type="fig"}), in toehold switches the RBS is not part of the double-stranded RNA structure, which allows more flexibility in the design of the switch and its cognate synthetic sRNA (Green *et al.*[@bib160]). In the example shown here, synthesis of one or more synthetic sRNA in the cell will allow ribosome binding and translation of the cognate ORFs (here represented by red, yellow, green and blue fluorescent proteins).](fuz001fig5){#fig5}

Regulation by covalent DNA modifications and DNA rearrangements {#sec1-7}
---------------------------------------------------------------

Other mechanisms by which the activity of bacterial promoters may be regulated involve the (reversible) chemical modification of bases or changes to the DNA sequence. These modifications may affect the affinity of the DNA for a TF or for RNAP (Nou *et al.*[@bib306]; Blomfield [@bib36]). The most common bacterial chemical modification is DNA methylation, especially of adenine. It is not only used in transcription regulation, pathogenesis and virulence (van der Woude, Braaten and Low [@bib426]; Low, Weyand and Mahan [@bib247]; Heusipp, Fälker and Schmidt [@bib186]), but methylated and hemi-methylated DNA are also involved in regulation of replication initiation, DNA repair, transposition and restriction/modification systems, and may be regarded as a form of bacterial epigenetic regulation (Adhikari and Curtis [@bib2]; Casadesús [@bib63]). Another form of local DNA sequence variation consists of tracts of variable length that repeat a single nucleotide or dinucleotide, often in the vicinity of the --35 promoter element. Here individual cells in a population carry a different number of repeats in the variable region, with each tract length corresponding to a different expression level. As an example, variation in length of a C-tract influences the interaction between the activator protein BvgA (response regulator of virulence genes) and RNAP in the promoter region for fimbrial subunits in *Bordetella pertussis* (Chen *et al.*[@bib81]). Similarly, variations in length of a short sequence repeat in the control region of the *nadA* adhesion gene of *Neisseria meningitides* affects the binding of the repressor NadR (Metruccio *et al.*[@bib273]). Thus, at any moment, variation in short sequence repeats ensures that a subset of cells in the population will have the optimal level of transcription activity for the given condition (van der Woude [@bib425]). This regulation 'by lottery', which is driven by repetitive sequences that differ in number from one generation to another, contrasts sharply with regulation by classical TFs for which the effect can be balanced/fine-tuned to the intensity of the input signal.

Another regulatory system involving sequence variation consists in the inversion by site-specific DNA recombination of a DNA segment containing a promoter in response to a particular signal (note that this process may be affected by DNA methylation). Such invertible promoters will switch the expression either 'ON' or 'OFF', depending on their orientation with respect to the cognate ORFs. Such a DNA switching mechanism is used in the control of fimbrial gene expression in *E. coli* (Corcoran and Dorman, [@bib97]). Again, such an all-or-none mechanism is in contrast with the action of TFs.

Finally, it is worth noting that some mobile insertion sequences (IS) such as IS*3* carry an outward oriented promoter that may reactivate a silent gene upon transposition in its vicinity. Hence, such elements may be considered as mobile promoters (Charlier, Piette and Glansdorff [@bib76]).

Differential regulation of RNAP activity by small molecules and substrates {#sec1-8}
--------------------------------------------------------------------------

Besides the binding of alternative σ factors, small ligands that directly interact with the bacterial RNAP provide a mechanism by which the enzyme can respond swiftly and efficiently to environmental changes. The best studied of such small ligands is likely the alarmone ppGpp (guanosine 3΄-diphosphate, 5΄-diphosphate) that binds near the active site of *E. coli* RNAP and interacts with the β and β΄ subunits (Artsimovitch *et al.*[@bib16]; Ross *et al.*[@bib361]). In *E. coli* and other Gram-negative bacteria, but not in Gram-positives (see below), ppGpp exerts its effects in cooperation with DksA (DnaK suppressor), a protein that binds in the secondary (dNTP substrate binding) channel of the polymerase and amplifies the regulatory impact of ppGpp by reducing the longevity of the RNAP--promoter complex (Paul *et al.*[@bib318]; Perederina *et al.*[@bib325]; Vrentas *et al.*[@bib429]; Lennon *et al.*[@bib237]). ppGpp (and pppGpp that is converted into ppGpp) is synthesized by ribosome-associated RelA (relaxed) in response to metabolic stress, when amino acid availability is restricted to the extent that translation is limited and uncharged tRNAs accumulate in the A site of ribosomes, and SpoT (a hydrolase that can also function as a synthetase). ppGpp-dependent inhibition of transcription generally occurs at promoters that form unstable open complexes (Barker, Gaal and Gourse [@bib23]; Barker *et al.*[@bib24]; Magnusson, Farewell and Nyström [@bib264]; Dalebroux and Swanson [@bib100]; Mechold *et al.*[@bib271]). These so-called stringent promoters typically have a short G+C-rich sequence stretch (discriminator box) near the start of transcription that forms a high-energy barrier for the isomerization from the closed to the open complex and is non-optimally contacted by σ^700^ region 1.2 (Haugen *et al.*[@bib175]). Stringent promoters are generally associated with genes encoding products involved in translation (e.g. ribosomal RNAs and proteins), DNA replication and pyrimidine nucleotide synthesis such as the *E. coli carAB* and *pyrBI* (aspartate transcarbamylase) operons (Turnbough [@bib418]; Bouvier, Patte and Stragier [@bib43]; Burgos *et al.*[@bib53]). Stringent promoters generally also perform poorly at low concentrations of the initiating nucleotide, mostly ATP. It has been proposed that ppGpp controls expression of the translation machinery in response to sudden starvation, whereas ATP availability controls expression in response to growth rate (Paul *et al.*[@bib318]). Besides these negative effects, ppGpp also positively influences the expression of numerous genes and pathways, including amino acid biosynthesis and uptake, universal stress proteins and *rpoS*, encoding the alternative sigma factor σ^S^ that itself affects transcription initiation at σ^S^-dependent promoters (Magnusson, Farewell and Nyström [@bib264]). It has also been proposed that ppGpp redistributes the available RNAP between stringent (characterized by unstable open complexes) and non-stringent (characterized by lower RNAP-binding affinity and/or the requirement for an alternative σ factor) promoters (Carmona *et al.*[@bib61]; Kvint, Farewell and Nyström [@bib226]; Barker, Gaal and Gourse [@bib23]; Laurie *et al.*[@bib231]). ppGpp-dependent regulation is complex and not fully unraveled, and although the stringent response is rather well conserved among bacterial species, it also exhibits differences related to the particular lifestyle of the organism in both the players involved in sensing and responding to stimuli, and the downstream targets (Boutte and Crosson [@bib41], [@bib42]; Corrigan *et al.*[@bib98]; Pulschen *et al.*[@bib339]). In Gram-positive bacteria, the effect of (p)ppGpp is rather indirect and mediated by lowering the intracellular levels of GTP, which leads to a decrease in transcription of mRNAs with a GTP-initiating nucleotide, including most rRNA promoters (Krásny and Gourse [@bib223]; Srivatsan and Wang [@bib400]; Wolz, Geiger and Goerke [@bib443]).

The bacterial RNAP holoenzyme incorporates its four nucleoside triphosphate (NTP) substrates with different efficiency (CTP \> ATP \> GTP \> UTP) and its activity is affected by fluctuations in the levels of these NTPs, with the concentration of the initiating NTP (iNTP) being the most crucial. Some promoters, including those of rRNA, some tRNAs and *fis*, require even higher concentrations of the iNTP than promoters on average. As a consequence, depletion of NTPs in extended stationary growth phase particularly affects these promoters (Murray, Schneider and Gourse [@bib291]; Sojka *et al.*[@bib393]).

At some promoters such as the *pyrC* (dihydroorotase) and *pyrD* (dihydroorotate dehydrogenase) genes of *E. coli* and *S.* Typhimurium, the ratio of different NTPs will determine the choice of the starting nucleotide and this will in turn affect the potential of the resulting mRNA to form a more or less stable secondary structure at its 5΄-end (Kelln and Neuhard [@bib212]; Frick, Neuhard and Kelln [@bib143]; Sørensen *et al.*[@bib396]; Liu and Turnbough [@bib242]; Turnbough and Switzer [@bib420]). At high intracellular CTP/GTP ratios *pyrC* and *pyrD*, transcription will preferentially start with CTP, 6 to 7 nt downstream of the Pribnow box. This transcript has two extra C-residues at the 5΄-end that are not present in the transcript that is made at low CTP/GTP ratios and starts with a guanosine residue. The presence of two extra C-residues allows the formation of a stable secondary structure at the 5΄-end of the mRNA that sequesters the RBS and hence inhibits translation initiation. Thus, even though the initial signal is sensed by the initiating RNAP, the final regulatory outcome is situated at the translational level. However, further emphasizing the intertwinement of regulatory processes, the reduced translation initiation of the longer *pyrC* transcript also affects its degradation rate (Wilson, Chan and Turnbough [@bib439]; Wilson *et al.*[@bib438]).

High UTP concentrations and local nucleotide sequence near the transcription start site may also result in reiterative transcription or 'stuttering' of the RNAP, which is the repeated addition of the same nucleotide at the 3΄-end of the growing transcript (Turnbough [@bib419]). Stuttering is due to slippage between the growing transcript and the DNA template and typically occurs at stretches of at least three consecutive identical nucleotides in the template (Xiong and Reznikoff [@bib446]; Cheng, Dylla and Turnbough [@bib87]). It results in the addition of a homopolymeric RNA stretch and inhibits further downstream elongation. After the addition of a number of identical residues, the transcript can either dissociate from the initiating transcription complex or proceed to the normal addition of nucleotides and productive elongation. In *E. coli*, several genes and operons of the pyrimidine nucleotide metabolism (biosynthesis, uptake and interconversion, together \>30 genes) are at least in part regulated by reiterative transcription (Turnbough [@bib419]). All what is required appears to be a stretch of at least three consecutive thymidine residues in the non-template strand shortly after the start of transcription. As an example, the 5΄-end of the *pyrBI* transcript has the sequence 5΄-AATTTG. High intracellular UTP concentrations result in the abundant synthesis of short transcripts with the sequence AAUUUn (with n 1 to \>30), and this inhibits the production of normal productive transcripts by approximately 7-fold (Liu, Heath and Turnbough [@bib241]).

Regulation of mRNA stability {#sec1-9}
----------------------------

mRNA degradation plays a key role in controlling gene expression in bacteria, where decay rates can differ from less than a minute to more than an hour (Rauhut and Klug [@bib346]). RNA stability is important for setting both the number of mRNA molecules that may be translated into functional proteins and the number of sRNAs that can exert a regulatory function (see the section Regulation of gene expression by small RNAs). mRNAs that are not actively translated are prone to Rho-dependent transcription termination and mRNA degradation by the membrane-bound degradosome, a large macromolecular complex that in *E. coli* comprises RNase E (endonuclease), PNPase (polynucleotide phosphorylase, exonuclease) and RNA helicase (Carpousis [@bib62]). Degradation generally starts with internal cleavage of the mRNA by RNase E, which preferentially cuts in A+U-rich single-stranded regions, but may also be initiated from the 5΄-end (Nillson and Uhlin [@bib304]; Mackie [@bib259], [@bib260]; Luciano *et al.*[@bib250]). Access of the degradosome to these sites can be blocked by initiating or elongating ribosomes and, as a consequence, transcripts that have reduced translation may be subject to more rapid degradation (Deana and Belasco [@bib108]). Additionally, though less frequently, RNA decay in *E. coli* starts with cleavage by other endonucleases, such as RNase III, RNase G (a paralog of RNase E), RNase P (a ribozyme involved in maturation of the 5΄-end of tRNA molecules) or RNases from toxin--antitoxin modules (Kaga *et al.*[@bib205]; Deutcher [@bib116]; Richards and Belasco [@bib354]; Masuda and Inouye [@bib268]). RNase E can bind monophosphorylated but not di- and triphosphorylated RNA ends, and there is now growing evidence suggesting that the triphosphate structure at the 5΄-end of bacterial mRNA plays a protective role against degradation, similar to the role of the eukaryotic 5΄-cap site (Luciano *et al.*[@bib250]). Its conversion into a 5΄-monophosphate end would then initiate a cascade of endo- and exoribonuclease catalyzed cleavages. The RNA pyrophosphohydrolase RppH plays a crucial role in this process but even though the enzyme is capable of removing pyrophosphate from the 5΄-end of a transcript it is much more active on dephosphorylated ends. In *E. coli*, the conversion of the triphosphate to the monophosphate 5΄-end appears to start with the removal of the γ phosphate by an as yet unidentified enzyme, followed by the RppH-catalyzed removal of the β phosphate (Luciano *et al.*[@bib250]). RppH is conserved in diverse bacterial species and is involved in the degradation of many but not all mRNAs as it shows some sequence preference (two unpaired nucleotides at the end and preference for a purine in second position). Its activity is modulated by the DapF protein (diaminopimelate isomerase) that forms a complex with RppH (Lee *et al.*[@bib234]; Gao *et al.*[@bib147]). RppH is involved in various crucial cellular processes, including virulence, ribosome biogenesis and resistance to osmotic shock. Its association with an enzyme (DapF) involved in the biosynthesis of lysine and peptidoglycan is therefore intriguing, especially since the catalytic activity of the enzyme is not required for its moonlighting stimulatory action on RppH-dependent mRNA decay (Lee *et al.*[@bib234]). Remarkably, RNase E itself also associates with a metabolic enzyme, the glycolytic enzyme enolase, but little is known about this association (Chandran and Luisi [@bib70]).

RNase E-dependent cleavage in intercistronic regions is also used to differentially regulate the expression of distinct genes of an operon. As an example, RNase E-dependent processing in the intercistronic *papB-papA* region of the bicistronic *papBA* mRNA involved in Pap pili synthesis in uropathogenic *E. coli* results in the accumulation of the *papA*-specific mRNA (encoding the major structural protein of the pilus shaft) over the initially produced bicistronic *papBA* and *papB* mRNA (encoding the PapB transcriptional regulator), the latter being rapidly degraded (Nilsson and Uhlin [@bib304]; Nilsson, Naureckiene and Uhlin [@bib303]). Additional differential expression of more downstream located genes in the *papBAHCDJKEFG* operon is generated by partial transcription termination at a terminator, situated between *papA* and *papH*, that considerably reduces the amount of downstream transcripts (Båga *et al.*[@bib20]).

Evidently and inevitably, mRNA decay rates will be directly linked to other gene regulatory processes affecting the translation initiation frequency such as translational attenuation and translation elongation rates, to the binding of small antisense RNAs and proteins, and to environmental effects affecting mRNA structure such as temperature, pH, salt concentration and the binding of small effector molecules, mainly to the 5΄-UTR (see the sections Regulation of gene expression by RNA-binding proteins, Riboswitches: RNA sensors and RNA thermometers, and Regulation of gene expression by small RNAs). Furthermore, the degradation of some mRNA species in *E. coli* is regulated in a growth rate-dependent manner (Nilsson *et al.*[@bib302]).

Regulation of gene expression by RNA-binding proteins {#sec1-10}
-----------------------------------------------------

Regulatory proteins that bind specific RNA sequences or structures (RBPs) may modulate gene expression through different mechanisms: (i) directly affect the susceptibility of the target RNA to degradation, (ii) modify the accessibility of the RBS for ribosome binding (either positively or negatively), (iii) act as a chaperone for interaction of the target with other effector molecules (including sRNAs) and (iv) alter the formation of transcription terminator/anti-terminator structures (Fig. [6](#fig6){ref-type="fig"}) (Duval *et al.*[@bib124]). Just as ribosomes, some RBPs including Hfq may exert their effect by directly shielding the recognition sites of RNases in mRNAs or small regulatory RNAs, thus protecting them from degradation (Moll *et al.*[@bib284]). Hfq thus not only promotes or facilitates the interaction between small regulatory RNAs (sRNA) and their target mRNA, as illustrated above (regulation of σ^S^), but may also directly protect mRNAs and sRNAs from RNase E cleavage, as demonstrated for the OmpA mRNA and the sRNAs DsrA and RyhB (Moll *et al.*[@bib284]). Other RBPs affect the secondary structure of their cognate mRNA targets upon binding, resulting in RNase recognition sites that become buried or more exposed, thus positively or negatively affecting the stability of these molecules (Fig. [6A](#fig6){ref-type="fig"}). Furthermore, RNA-modifying enzymes or RBPs that actively recruit RNases may influence the mRNA turnover (see the section Regulation of mRNA stability) (Fig. [6C](#fig6){ref-type="fig"}).

![Regulation of mRNA stability and regulation of bacterial translation and transcription with RNA-binding proteins (RBP). (**A**) Regulated access to ribonucleases. A RBP (blue colored) may directly compete with the binding of a nuclease (yellow colored) to an overlapping site on the mRNA, liberate a recognition site for a ribonuclease on the mRNA resulting in a negative effect on gene expression or favor the formation of a secondary structure in which the target site (yellow colored box) for the ribonuclease is not readily accessible. The latter results in a positive effect on gene expression. (**B**) Regulated translation initiation. A RBP may (i) directly compete with the ribosome (30S subunit) for binding to the RBS (magenta box), (ii) favor the formation of structure in which the RBS is trapped in a double-stranded secondary structure, (iii) favor the formation of a secondary structure that liberates the RBS, hence facilitating ribosome binding and stimulating translation, (iv) inhibit translation initiation by stabilizing a complex in which the 30S subunit of the ribosome is trapped in an incompetent state by the RNA and (v) indirectly inhibit translation initiation by generating a steric clash with ribosome binding to the RBS. Green colored rectangles represent ORFs. (**C**) Improved access to proteases by the chaperone function of the RBP that may act in conjunction with a small regulatory RNA (green line) complementary to the mRNA. (**D**) Transcriptional attenuation. A RBP may positively or negatively affect premature transcription termination by stabilizing a terminator structure (dark red colored hairpin), or, inversely, by stabilizing an anti-terminator structure (sea-green colored hairpin), or still by exposing a recognition site for a transcription terminator protein such as Rho (bright red colored) (or alternatively a target site for a ribonuclease).](fuz001fig6){#fig6}

Translation initiation requires binding of ribosomes to the RBS. However, accessibility of the RBS is not only important for translation initiation but also influences the extent to which the mRNA may be degraded or even completely transcribed. Therefore, bacteria have evolved a variety of distinct mechanisms to regulate gene expression by limiting the accessibility of the RBS for ribosome binding (Fig. [6B](#fig6){ref-type="fig"}). One such mechanism concerns negative autoregulation, where a RBP binds to the 5΄-end of its own transcript, thus shielding the RBS and inhibiting translation initiation. Examples of this strategy are ribosomal proteins in *E. coli* and *Vibrio cholera* (Zengel and Lindahl [@bib452]; Allen *et al.*[@bib5]) and the *thrS* operon (encoding threonyl-tRNA synthetase) of *E. coli*, where molecular mimicry (5΄-leader mRNA structure resembles the tRNA substrate) is used for binding (Springer *et al.*[@bib399], [@bib398]). It is thus a widespread mechanism that extends beyond the Enterobacteriaceae. There are however several ways by which RBPs can inhibit translation. The most common is a 'competitive' mechanism, where the RBP and the 30S ribosomal subunit compete for binding to the RBS (Fig. [6B](#fig6){ref-type="fig"}). In another mechanism called 'entrapment', the 30S subunit is trapped at the RBS during initiation to prevent further steps in the translation process (Fig. [6B](#fig6){ref-type="fig"}). Here, a ternary complex is formed between the mRNA, the 30S subunit and the regulatory RBP, in which the 30S subunit is trapped in an incompetent state by the mRNA and this state is stabilized by the RBP (Springer *et al.*[@bib399]; Philippe *et al.*[@bib330]). The trapping mechanism appears to be very efficient to inhibit translation when the repressor concentration and/or its affinity is low. Lastly, an RBP may change the secondary structure of the region surrounding the RBS and influence ribosome binding at a distant region (Fig. [6B](#fig6){ref-type="fig"}).

Besides autoregulatory RBPs, bacteria may contain a number of dedicated regulatory RNA-binding proteins such as BpuR, CspA, CsrA, PyrR and TRAP. Likely the best-characterized example is *E. coli* CsrA (carbon storage regulator A) and its othologs RsmA/RsmE (repressor of secondary metabolites) in *Erwinia carotovora* and *Pseudomonas*. CsrA affects the simultaneous expression of various mRNAs involved in multiple processes, including carbon metabolism, peptide transport, biofilm formation, motility, quorum sensing and virulence (reviewed in Romeo, Vakulskas and Babitzke [@bib359]). CsrA may either inhibit or stimulate gene expression (Romeo, Vakulskas and Babitzke [@bib359]; Duval *et al.*[@bib124]; Vakulskas *et al.*[@bib421]; Potts *et al.*[@bib337]). CspA (cold-shock protein A) plays a major role in the control of cold-shock genes (Gualerzi, Giuliodori and Pon [@bib167]). The activity of some RBPs is modulated by interaction with a small effector molecule. They act as allosteric regulators. Thus, binding to and stabilization of particular secondary structures (anti-anti-attenuators) in the 5΄-leader by PyrR (pyrimidine regulator) and TRAP (tryptophan-regulated attenuation protein) from *B. subtilis* is modulated by the concentration of PRPP (phosphorybosylpyrophosphate) and UMP/UTP, and tryptophan, respectively (Babitzke and Yanofsky [@bib19]; Lu and Switzer [@bib249]; Babitzke [@bib18]; Turnbough and Switzer [@bib420]). PyrR and TRAP affect premature transcription termination (attenuation type of control) in pyrimidine and tryptophan biosynthesis, respectively (Fig. [6D](#fig6){ref-type="fig"}). In addition, TRAP binding also represses translation initiation of the first ORF of the polycistronic *trp* mRNA of *B. subtilis*. Furthermore, the activity of TRAP is regulated by anti-TRAP that is induced upon accumulation of uncharged tRNA^Trp^ and forms a complex with TRAP, in competition with mRNA binding to the RNA-binding domain of TRAP (Valbuzzi and Yanofsky [@bib423]; Valbuzzi *et al.*[@bib422]).

Some other RBPs constitute a platform for the binding of other molecules (small RNA or protein) that will affect RNA stability or translation efficiency (Fig. [6C](#fig6){ref-type="fig"}). Thus, Hfq binds the sRNAs DsrA, RprA, ArcZ and the mRNA in the context of post-transcriptional regulation of σ^S^ production (Battesti, Majdalani and Gottesman [@bib26]; see regulation of σ^S^ in the section Regulation of gene expression by sigma factor competition), whereas other regulatory RBPs bind proteins facilitating mRNA degradation, such as PapI (*pap* operon regulatory protein) or the degradosome (Carpousis [@bib62]; De Lay, Schu and Gottesman [@bib110]).

Another mechanism by which RBPs affect gene expression is by modulating transcription elongation (Santangelo and Artsimovitch [@bib372]). Transcription by the RNAP proceeds until a terminator is reached. At intrinsic terminators, dissociation of the elongation complex is dependent on the mRNA sequence and structure, while factor-dependent terminators need the action of a protein factor such as Rho. Typically, these terminators are present at the end of an operon. However, some exist conditionally within the 5΄-leader region of the transcript. In case of intrinsic termination, RBPs can either favorize the formation of a terminator structure (also called attenuator) by binding to an anti-anti-terminator (and thus inhibiting the formation of the anti-terminator) or the formation of an alternative anti-terminator structure, which prevents the formation of the terminator (Fig. [6D](#fig6){ref-type="fig"}). Generally, the terminator and anti-terminator are mutually exclusive structures. As an example, the ribosomal protein L4 of *E. coli* interacts with a small hairpin structure in the polycistronic S10 mRNA encoding 11 small ribosomal proteins and in conjunction with NusA causes premature transcription termination at a Rho-independent termination site (Stelzl *et al.*[@bib402]). The activity of this type of RBPs is frequently modulated by binding of a small effector molecule, or controlled via their phosphorylation status. Examples are PyrR/PRPP-UTP and TRAP-trp of *B. subtilis*, as indicated above. A well-characterized family of widespread bacterial RNA binding anti-terminator proteins with members in Gram-negative and Gram-positive bacteria whose activity is modulated by phosphorylation/dephosphosphorylation is BglG. BglG family regulators control the expression of enzyme II (EII) carbohydrate transporters of the phosphotransferase system (PTS). *Escherichia coli* BglG, the prototype of the family, regulates expression of the *bglGFBH* operon that besides the regulator itself encodes the aryl-β-glucoside transporter BglF that belongs to the phosphoenolpyruvate-dependent PTS, and other proteins involved in the utilization of aryl β-glucoside sugars. Only dimeric BglG positively regulates the expression of the *bgl* operon by binding to sites that partially overlap two Rho-independent transcription terminators, thus stabilizing an alternative anti-terminator conformation (Mahadevan and Wright [@bib265]; Houman, Diaz-Torres and Wright [@bib193]). BglG consists of an RNA-binding domain and two homologous PTS regulation domains, PRD1 and 2, which contain two conserved phosphorylatable histidine residues that are important for the anti-terminator activity of BglG (van Tilbeurgh and Declerck [@bib427]). To be able to dimerize, the PDR1 domain of BglG has to be reversibly dephosphorylated by BglF, which only occurs when BglF is engaged in sugar transport (Amster-Choder and Wright [@bib8]; Görke [@bib156]). In the absence of β-glucoside substrates, BglG is recruited to the cell membrane by BglF that is phosphorylated by enzyme I of PTS and HPr (histidine containing phosphocarrier protein) and phosphorylated BglF and then passes its phosphoryl group to a histidine residue present in the PDR1 domain of BglG, thus inactivating the regulator. In the presence of β-glucosides, however, BglF will rather transfer its phosphoryl group to the sugar molecules and BglG gets dephosphorylated at this site. In addition to this dephosphorylation reaction, activation of BglG requires phosphorylation at histidine residue 208 in its PDR2 domain, a reaction that is catalyzed by HPr (or its paralog FruB) (Rothe *et al.*[@bib362]). The latter appears to act as a carbon catabolite mechanism that downregulates BglG activity when other PTS sugars are available in addition to β-glucosides. In these conditions, sugar transport will drain phosphoryl groups from HPr, leading to less phosphorylated BglG (Görke and Rak [@bib157]). Furthermore, RBPs can also play a role in Rho-dependent termination by inducing a change in the secondary structure of the mRNA, thus exposing a Rho-utilizing site (*rut*) that is otherwise inaccessible (Fig. [6D](#fig6){ref-type="fig"}).

Finally, RNA-binding proteins may also function as anti-terminators by interacting directly with the elongating RNAP complex and acting at a distance (Greenblatt, Nodwell and Mason [@bib162]; Santangelo and Artsimovitch [@bib372]). The first reported and best-characterized example hereof is the bacteriophage λ protein N that allows the transition between the transcription of early and middle genes of the bacteriophage (Gottesman, Adhya and Das [@bib158]). N binds to the '*nut*' sites (N-utilization) in the early mRNA molecules initiated from the promoters P~R~ and P~L~ and functions as an anti-terminator, allowing the host RNAP to proceed beyond the terminators t~R1~ and t~L1~ (Barik *et al.*[@bib22]; Nodwell and Greenblatt [@bib305]; Rees *et al.*[@bib349]). N binds to a 15 nt stem loop structure near the 5΄-end of the P~L~ and P~R~ transcripts, moves along with the elongating RNAP and acts in conjunction with the host encoded Nus proteins (N-utilizing substance) NusA, B, G and ribosomal protein S~10~ to override the downstream terminator sites (Schauer *et al.*[@bib373]; Mason and Greenblatt [@bib267]; Mogridge, Mah and Greenblatt [@bib282]; Gusarov and Nudler [@bib169]; Conant *et al.*[@bib95]). Remarkably, NusA is itself part of the *E. coli* termination machinery but in conjunction with N it participates in anti-termination.

Riboswitches: RNA sensors and RNA thermometers {#sec1-11}
----------------------------------------------

Some mRNA molecules have the capacity to fold into complex and very specific tertiary structures, generally in their 5΄-UTR, that can act as sensors for different types of chemicals and physical parameters such as small ligands and temperature or pH (Serganov and Nudler [@bib380]) (Fig. [7](#fig7){ref-type="fig"}). Aptamers or natural mRNA sensors that specifically recognize small molecules are better known as riboswitches as they have the ability to 'switch' between alternative mRNA conformations that alter gene expression. As riboswitches are an integral part of the mRNA molecule they exclusively act in *cis*. Riboswitches consist of two distinct but overlapping domains: an aptamer domain that contains the selective binding site and an expression platform that influences gene expression. They act as genetic switches in response to various metabolites including amino acids, vitamins, S-adenosyl methionine, guanine, FMN, thiamine pyrophosphate, ions and second messenger molecules such as c-di-GMP \[Bis-(3΄-5΄)-cyclic dimeric guanosine monophosphate\] that play an important role as signaling molecule in various processes in both Gram-negative and Gram-positive bacteria, including the control of community behavior, motility, biofilm formation, cell morphogenesis and virulence (Winkler, Cohen-Chalamish and Breaker [@bib441]; Winkler, Nahvi and Breaker [@bib442]; Smith *et al.*[@bib391]; Bordeleau *et al.*[@bib37]; Furukawa *et al.*[@bib144]; Peltier and Soutourina [@bib324]). Riboswitches may affect both translation initiation (by sequestering or freeing a RBS) and transcription termination (attenuation control, by favorizing the formation of either terminator or anti-terminator structures) (Fig. [7A and B](#fig7){ref-type="fig"}). Furthermore, changes in RNA conformation due to ligand binding can directly regulate access to Rho- or RNase E-binding sites, or still may affect mRNA stability via self-cleavage through ligand-induced ribozyme activity (Winkler, Cohen-Chalamish and Breaker [@bib441]; Winkler, Nahvi and Breaker [@bib442]; Serganov and Nudler [@bib380]). Many riboswitches even combine multiple mechanisms that act in parallel and a single transcript may contain more than one sensor domain, each one binding a specific ligand. In such an organization, they have the potential to act as a two-input logic gate where both cognate compounds are required for modulation of gene expression to occur (Sharma, Nomura and Yokobayashi [@bib383]).

![Riboswitches: RNA sensors and RNA thermometers. (**A**) Ligand (magenta sphere) induced formation of transcriptional terminator or anti-terminator RNA structures in the mRNA (green colored) that result in premature transcription termination of the RNAP (gray colored) or allow downstream transcription elongation, respectively. (**B**) Translational attenuation mechanisms whereby ligand binding traps the RBS (magenta box) in a RNA secondary structure and is not accessible for ribosome (yellow colored) binding or, inversely, stabilizes an alternative structure and frees the RBS, thus allowing initiation of translation. (**C**) RNA thermometer. Here the RBS is trapped in a secondary structure and not available for ribosome binding. Melting of this structure in a zipper-like manner at increasing temperatures liberates the RBS, thus allowing translation initiation. (**D**) Reversible and temperature-dependent formation of alternative secondary RNA structures that may affect premature transcription termination or translation initiation.](fuz001fig7){#fig7}

In addition to small molecules, different RNA folds, which depend on thermodynamic stabilities, are strongly affected by temperature (Fig. [7C and D](#fig7){ref-type="fig"}). Different thermoresponsive elements, also called RNA thermometers, have been described that allow translation at both elevated or depressed temperatures, and regulate genes associated with cold- or heat-shock response, and virulence genes (Johansson *et al.*[@bib203]; Gualerzi, Giuliodori and Pon [@bib167]; Kortmann and Narberhaus [@bib221]). Examples are the *rpoH* (σ^H^), *agsA* and *hsp17* genes mediating heat-shock response in respectively *E. coli*, *Salmonella enterica* and *Synechocystic* sp. PCC 6803 and the *cIII* gene of bacteriophage lambda that favors lysogeny (Altuvia *et al.*[@bib6]; Morita *et al.*[@bib288]; Waldminghaus *et al.*[@bib430]; Kortmann *et al.*[@bib222]). RNA thermometers tend to be relatively simple structures compared to riboswitches that bind small ligands. As a consequence, their presence is difficult to identify/predict in genomic sequences. As riboswitches and RNA thermometers do not require any other regulatory element besides the mRNA itself, and as they exist in the three domains of life, they might represent the oldest forms of gene regulation, already present in the hypothesized RNA world. All currently identified naturally occurring RNA thermometers regulate gene expression at the level of translation initiation. However, recently, the temperature-dependent destabilization of RNA thermometer structures (combined with a U-stretch) was exploited to construct a temperature-responsive transcription terminator (Roßmanith, Weskamp and Narberhaus [@bib357]).

Finally, riboswitches may also sense and interact with uncharged tRNA molecules. In Gram-positive bacteria such as *B. subtilis*, the expression of many aminoacyl-tRNA synthetase genes and genes involved in amino acid biosynthesis and uptake are regulated by an anti-termination mechanism, in which a specific uncharged tRNA interacts with a cognate 'T box' sequence in the 5΄-leader region of the transcripts (Condon, Grunberg-Manago and Putzer [@bib96]; Putzer *et al.*[@bib340]; Green, Grundy and Henkin [@bib161]). This interaction stabilizes an anti-terminator element that competes with the terminator, and hence promotes expression of downstream coding sequences.

Regulation of gene expression by small RNAs {#sec1-12}
-------------------------------------------

mRNAs can also adopt structures that act as sensors for small regulatory RNAs that affect gene expression via RNA--RNA interactions (Saberi *et al.*[@bib366]). Anti-sense regulatory RNAs can be divided into *cis*-acting and *trans*-acting regulatory molecules. *Cis*-acting RNAs are antisense RNAs, transcribed from the opposite DNA strand and show perfect bp complementarity to the mRNA target. They can vary in size from a few tens to thousands of nucleotides and their abundance in different bacteria varies extensively (Thomason and Storz [@bib414]). Anti-sense RNAs can affect transcription in essentially two manners: transcription interference or transcription attenuation (Fig. [8A](#fig8){ref-type="fig"}). Transcription interference occurs when transcription initiated from one promoter is restrained by the action of a second promoter in *cis*. Attenuation is a mechanism that causes premature termination of transcription. Base pairing of antisense RNA to the cognate mRNA may induce the formation of a Rho-independent terminator, resulting in an aborted non-functional transcript, or in contrast, induce the formation of an anti-terminator structure thus allowing production of a full-length functional transcript. Another potential mode of regulation by antisense RNAs is to either promote or inhibit degradation of the target mRNA by endo- or exoribonucleases. In bacteria, the endoribonucleases RNase III and RNase E have for instance been linked to RyhB (sRNA regulator of iron acquisition and utilization) antisense RNA-induced target cleavage of *sodB* mRNA, encoding superoxide dismutase B (Afonyushkin *et al.*[@bib3]).

![Regulation by small RNAs (sRNAs). (**A**) Regulation of mRNA translation (top part) and transcription attenuation (bottom part) by *cis*-acting antisense sRNAs. A *cis*-acting sRNA (blue colored) encoded from the opposite strand as its target gene (green colored) inhibits gene expression at the post-transcriptional level by sequestering the ribosome-binding site (magenta colored rectangle) in a double-stranded RNA secondary structure. Transcriptional attenuation results from sRNA induced formation of a terminator (attenuator; red colored hairpin) structure in the mRNA at the expense of the anti-terminator. (**B**) Three methods illustrating gene regulation by *trans*-acting sRNAs. *Trans*-acting sRNAs are only partially complementary to the target RNA and frequently require the help of a chaperone protein (blue ellipse) such as Hfq in *E. coli* for stabilization, folding and target binding. Due to the limited bp complementarity with the target, *trans*-acting sRNAs may bind several distinct mRNAs and either inhibit translation by sequestering the RBS, which may also lead to accelerated mRNA degradation (top part), or inversely free the RBS and hence stimulate translation (middle part). Finally, *trans*-acting sRNAs bearing multiple binding sites for an inhibitory RNA-binding protein (RBP, blue colored ellipse) indirectly stimulate translation of one or more mRNAs by titration/sequestration of the RBP (bottom part).](fuz001fig8){#fig8}

Some *cis*-encoded antisense RNA molecules are produced from plasmids as part of copy-number control systems (RNAI/RNAII of ColE1) (Lacatena and Cesarini [@bib227]), toxin/antitoxin systems (Afonyushkin *et al.*[@bib3]; Thomason and Storz [@bib414]), the production of potentially toxic proteins such as SymE (Fozo, Hemm and Storz [@bib138]) or are involved in the control of transposition frequencies via regulation of transposase synthesis, as observed for IS*10* and Tn*10* (Kleckner *et al.*[@bib218]). The SymR antisense RNA overlaps the 5΄-end of *symE* mRNA thus trapping the RBS in a double-stranded RNA structure, which results in repression of *symE* mRNA translation and enhanced mRNA degradation. Additionally, base pairing between sense and antisense RNA may impact translation of the target mRNA at a RBS distant from the region of interaction by altering the mRNA structure. In most instances, the utilization of antisense RNA as a regulation strategy adds an extra layer of regulation to systems whose expression is already extensively controlled by other mechanisms.

*Trans*-acting small regulatory RNAs are encoded from loci other than their target genes (Fig. [8B](#fig8){ref-type="fig"}). They are generally about 100 nucleotides long and share limited sequence complementarity with their target and may therefore act on multiple mRNAs in response to environmental cues as pH, temperature and nutrient depletion (Thomason and Storz [@bib414]). Regions of complementarity to the target consist of a seed region of 6--8 contiguous bp, which is the most conserved part of the sRNA. In *E. coli*, the RNA-binding protein Hfq is generally required to mediate sRNA--mRNA hybrid formation with *trans*-acting small regulatory RNAs. In this role, Hfq acts as a RNA chaperone to facilitate bp formation and stabilizes the sRNA against degradation (Peer and Margalit [@bib321]; Desnoyer and Massé [@bib114]). sRNAs make use of a variety of mechanisms such as direct binding to the RBS, enhancement of translation by interaction with a transcript that inhibits formation of mRNA secondary structures, guiding Hfq to a site for direct inhibition of translation or titration/sequestration of a RBP by binding to multiple binding sites on the sRNA (Fig. [8B](#fig8){ref-type="fig"}). The latter is how several *trans*-acting sRNAs including RsmW, RsmY, RsmZ and RsmV operate to titrate the RNA-binding proteins RsmA and/or RsmF that affect mRNA translation of genes involved in the inverse control of acute and chronic virulence in *P. aeruginosa* (Janssen *et al.*[@bib200], [@bib201]). As with other forms of regulation, repression of translation by sRNAs may lead to mRNA decay. A single transcript may be targeted by several sRNAs as it occurs for the *rpoS* transcript, involved in stress response and stationary phase growth, that is targeted by DsrA, RprA and ArcZ that all bind the same region of the *rpoS* transcript to alter its secondary structure, resulting in enhanced translation efficiency and increased *rpoS* mRNA stability in a highly additive manner (Battesti, Majdalani and Gottesman [@bib26]) (see also above regulation of σ^S^).

Regulatory RNA and synthetic biology {#sec1-13}
------------------------------------

Riboswitches may be advantageously exploited to control gene expression in synthetic pathways as they show (or may be engineered to) high selectivity and dose-dependent control of gene expression and may be used in different hosts. Indeed, as riboswitches do not involve the action of proteins they are supposed to be better transferable to different hosts, to be less cost intensive and faster than protein mediated gene regulation. Furthermore, as they show a modular composition of sensor and response elements they may be combined in a 'plug-and-play-like' mode (Etzel and Mörl [@bib130]). However, as naturally occurring riboswitches generally bind cellular metabolites or molecules taken up by the cell such as amino acids and ions, they do not work in an orthogonal manner and their artificial induction may interfere with the host metabolism and vice versa variations in the host metabolism may compromise the use of the riboswitch as a regulatory element for heterologous gene expression. Therefore, engineering is necessary if riboswitches have to be exploited in synthetic biology. This is, however, not evident as there is a tight link between the riboswitch itself and the activity of the RBS that is generally affected by the riboswitch. Nevertheless, riboswitches have considerable potential since synthetic aptamers binding a small molecule of interest can be selected from randomized RNA libraries and the modular design of riboswitches allows the construction of chimeric ones by exchange of aptamer domains and expression platforms (Muranaka *et al.*[@bib290]; Garst, Edwards and Batey [@bib150]; Vinkenborg, Karnowski and Famulok [@bib428]; Ceres *et al.*[@bib68]; Robinson *et al.*[@bib355]; Folliard *et al.*[@bib137]; Harbaugh *et al.*[@bib172]). However, selective ligand binding alone is not sufficient. In order to function as a regulatory switch, the RNA has to undergo a clear ligand induced conformational change with appropriate kinetic and thermodynamic parameters that is translated in a regulatory outcome. Such artificial riboswitches may be selected by a combination of library screening for ligand binding by SELEX (Systematic Evolution of Ligands by Exponential Enrichment) and screening for expression using a dual-reporter gene system (Findeiß *et al.*[@bib135]; Groher *et al.*[@bib164]; Harbaugh *et al.*[@bib172]; Lotz and Suess [@bib246]). Artificial riboswitches may also be generated by dedicated engineering starting from naturally occurring riboswitches and exploiting structural data. Thus, starting from an adenine responsive riboswitch Robinson *et al.* ([@bib355]) created novel orthogonal and chimeric riboswitch--synthetic ligand pairs with superior *in vivo* gene induction properties that modulate either transcription or translation and are transferable in Gram-negative and Gram-positive bacteria. As a proof of concept, they were shown to regulate bacterial motility genes of *E. coli* and morphology genes in *B. subtilis*. In combination, and embedded in the 5΄-UTR of a single mRNA, artificial riboswitches could also be used to engineer logic gates such as AND and NAND (see Box [2](#box2){ref-type="boxed-text"} for definitions) (Sharma, Nomura and Yokobayashi [@bib383]). Limitations in the large-scale application of riboswitches as regulatory elements may a. o. be due to potential sensitivity to the genetic context (some riboswitches also affect the structure of the downstream located ORF), low tunability and variability in performance. Furthermore, to be really useful in synthetic biology for a wide range of applications, riboswitches must be modular. In an attempt to overcome these shortcomings, Folliard *et al.* ([@bib137]) used the activating addA riboswitch (binds 2-aminopurine) from *Vibrio vulnificus* and the repressing btuB riboswitch (binds adenosylcobalamin) from *E. coli* to develop ribo-attenuators. Riboattenuators consist of a short sequence, bearing a second RBS that is sequestered by a local hairpin, that is inserted between the primary RBS (sequestered by the riboswitch) and the gene of interest. This local hairpin can be opened by a ribosome initiated from the upstream located riboswitch RBS, thus allowing translation of the gene of interest upon freeing the RBS by ligand binding. Advantages of such a system are (i) that it insulates the downstream gene from conformational changes induced by ligand-induced modifications of the riboswitch structure and (ii) reduces variations in expression levels. Similar to metabolite-sensing riboswitches, RNA thermometers can be exploited for the efficient and specific control of gene expression and libraries of RNA thermometers with diverse sensitivity and threshold temperatures have been designed based on thermodynamic computations and experimental assays (Sen *et al.*[@bib379]). The modularity of riboswitches and RNA thermometers was exploited by Roßmanith and Narberhaus ([@bib356]) to generate combined regulatory devices with novel functionalities depending on both ligand binding and temperature sensing, which confer dual regulation at the level of transcription and translation.

The application of regulatory strategies based on synthetic *trans*-acting sRNA has a number of advantages. Their *trans*-acting character allows the simultaneous targeting of several expression units, target site selection is based on RNA-RNA hybridization according to a simple code compared to protein-RNA or protein--DNA recognition and its strength can be modulated by the creation of libraries. Furthermore, their small size generates little burden for the host cell allowing the simultaneous introduction and expression of multiple sRNAs in the same cell. Libraries of rationally designed synthetic *trans*-acting sRNAs composed of a scaffold sequence for the recruitment of Hfq and a target-binding sequence were for instance developed to modulate gene expression in the context of metabolic engineering for the overproduction of tyrosine and cadaverine in *E. coli* (Na *et al.*[@bib293]). Starting from the hypothesis that transcriptional attenuators are modular (in analogy with modularity of riboswitches) and consist of a domain responsible for antisense RNA binding and another for actuating the transcriptional regulation, Takahashi and Lucks ([@bib410]) developed orthogonal chimeric *trans*-acting RNA transcription regulators by fusing and mutagenizing sequences from five different translational attenuators. Toehold switches, *de novo* designed artificial regulators of gene expression, were developed to enable orthogonal post-transcriptional activation of translation in response to cognate *trans*-acting sRNAs (Green *et al.*[@bib160]). In toehold switches, translation of an output gene is only possible when a cognate trigger RNA is expressed, and the RNA-RNA interactions are mediated through linear--linear interactions, rather than loop-mediated interactions as in most other naturally occurring and synthetic systems (Fig. [5B](#fig5){ref-type="fig"}). This has the advantage of faster kinetics and stronger thermodynamics (due to the length of the interacting stretches). Furthermore, toehold switches do not rely on direct binding to the RBS for repression but rather on the enclosure of the RBS in a loop formed with secondary structures immediately preceding and following the start codon. This allows the engineering of trigger-switch RNA complexes with low secondary structure in proximity of the start codon and ensures efficient translation in the ON state of the switch. Based on these toehold switch systems, Green *et al.* ([@bib159]) further developed ribocomputing systems composed exclusively of *de novo* designed RNA nanodevices based on predictable and designable base-pairing rules that regulate gene expression at the post-transcriptional level in *E. coli*. In this setup, a single-extended RNA transcript is used to co-localize the circuit sensing, computation, signal transduction and output elements of the nanodevices. This has the advantage that it reduces signal loss, lowers the metabolic cost and improves circuit reliability. Although originally developed for *E. coli*, it should in principle be possible to implement these devices in other organisms. Finally, it is worth mentioning that bacterial CRISPR-Cas defense mechanisms of acquired immunity, naturally used to destroy foreign incoming DNA in the cell (Bhaya, Davidson and Barrangou [@bib33]) and massively applied for gene and genome editing purposes in all domains of life, have also been exploited to generate a non-destructive gene regulatory system in which the target selectivity is based on RNA-DNA hybridization. In these systems, a 'dead' or nuclease-null variant of Cas9 that still binds DNA but no longer cleaves it is brought to selected targets on the DNA in association with a single small *trans*-acting guide RNA (sgRNA) and acts as a transcriptional DNA-binding transcription regulator (Esvelt *et al.*[@bib129]). Furthermore, the CRISPR-Cas interference RNA was also used to expand the dynamic range of gene expression from T7 promoters (McCutcheon *et al.*[@bib257]).

Concluding remarks {#sec1-14}
------------------

Bacterial gene regulatory mechanisms are diverse and may operate at different levels and stages in the flow of genetic information. As abundantly documented in this review, gene regulation is generally multi-layered and relies on a combination of different regulatory strategies integrating multiple signals. As these mechanisms are intrinsically intertwined, they are difficult to unravel. Generating a comprehensive picture of a regulatory circuit requires both specific and global, genome-wide *in vivo* expression studies at mRNA and protein level, and in-depth *in vitro* biochemical and biophysical analyses to unravel the underlying molecular basis of the mechanisms. Over the years the basal transcription and translation machineries have been dissected in great detail and many regulatory mechanisms have been identified. But, unraveling their interplay in specific pathways and regulatory networks is much more challenging. Even today and after decennia of investigations, we still ignore how the expression of about 50% of the genes is regulated in *E. coli*, the best-studied organism, and the situation is even worse for other Gram-negative and Gram-positive model organisms and platforms for microbial production such as *P. aeruginosa*, *C. glutamicum*, *B. subtilis* and *Streptomyces* species to cite only a few. Even in spite of the recent development of genome-wide high-throughput techniques including RNA-seq and Chip-seq for genome-wide transcript quantification and identification of TF-binding sites, respectively, there is still need for new approaches for the systematic large-scale and in-depth unraveling of bacterial gene regulation (Belliveau *et al.*[@bib29]; Hör, Gorski and Vogel [@bib192]).

To exploit bacteria as cell factories in an economically competitive manner for the biological and sustainable production of various and complex compounds, it will be necessary to dispose of robust recombinant strains with high production yields. Synthetic biology facilitates the engineering of such organisms in a rational manner. The import of synthetic circuits of increasing complexity in a host requires the coordinated and fine-tuned expression of several genes without major interference with the host metabolism. Therefore, there is need for libraries of basic *cis*-acting gene expression elements including promoter and ribosome-binding sites spanning a wide range of activities, various orthogonal gene expression systems at transcriptional and translational level that may be used simultaneously in the same cell, and *trans*-acting regulatory elements allowing their fine-tuning. To allow the selection of the most productive and robust producing cells, it is imperative that all these elements may be combined efficiently in a combinatorial manner and analyzed in high-throughput screens. This requires a wide variety of standardized parts, toolboxes and seamless assembly techniques. Presently, synthetic biology applications are still in need of more and varied, well-defined parts and tools and will still profit from better characterization of basal and regulatory gene expression elements, including σ factors, TFs, sRNAs, riboswitches and RNA thermometers, and their incorporation in toolboxes to control gene expression at both transcriptional and translational levels in a predictable and tunable manner. Hence, studies unraveling the functioning of naturally occurring bacterial gene regulatory systems and the analysis of the behavior of their constituent parts in artificial systems may be reciprocally beneficial and have an impact at societal level. The fishing pond for such orthogonal elements could be considerably extended by in-depth analyses of less well-studied bacteria and might even be extended to archaeal genomes since these organisms possess regulatory transcription factors that are similar to their bacterial homologs. Furthermore, even eukaryotic DNA-binding motives such as the Zinc-finger with its small size and relatively simple mode of DNA binding and sequence selectivity (MacPherson, Larochelle and Turcotte [@bib261]) could be advantageously exploited to attract chimeric orthogonal regulatory molecules or (single subunit) RNAPs to selected cognate targets. Genome and metagenome mining, bioinformatics and computation to predict the behavior of artificial circuits are therefore expected to play a major role in future developments. It would also be worth to invest in the better characterization of regulatory networks of extremophilic bacteria as they might be better suited as chassis for sustainable microbial production, especially starting from renewable biomass such as low value agricultural waste products including stems and leaved that require pretreatment in harsh conditions.
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